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ABSTRACT 
 
BRIAN D BOWER: AN IN VITRO CHARACTERIZATION OF FUNCTIONAL INTERACTIONS 
BETWEEN PURIFIED TELOMERE REPEAT BINDING FACTORS 1 AND 2 AND RAD51 
RECOMBINASE 
(Under the direction of Jack D. Griffith) 
 
 
A growing body of literature suggests that the homologous recombination/repair (HR) pathway 
cooperates with components of the shelterin complex to promote both telomere maintenance and non-
telomeric HR.  This may be due to the ability of both HR and shelterin proteins to promote strand 
invasion, wherein a single-stranded DNA (ssDNA) substrate base pairs with a homologous double-
stranded DNA (dsDNA) template displacing a loop of ssDNA (D-loop).  Rad51 recombinase catalyzes D-
loop formation during HR, and telomere repeat-binding factor 2 (TRF2) catalyzes the formation of a 
telomeric D-loop that stabilizes a looped structure in telomeric DNA (t-loop) that may facilitate telomere 
protection.  We have characterized this functional interaction in vitro using a fluorescent D-loop assay 
measuring the incorporation of Cy3-labeled 90 nucleotide telomeric and non-telomeric substrates into 
telomeric and non-telomeric plasmid templates.  We report that pre-incubation of a telomeric template 
with TRF2 inhibits the ability of Rad51 to promote telomeric D-loop formation when pre-incubated with 
a telomeric substrate.  This suggests Rad51 does not facilitate t-loop formation, and suggests a 
mechanism whereby TRF2 can inhibit HR at telomeres.  We also report a TRF2 mutant lacking the 
dsDNA binding domain promotes Rad51-mediated non-telomeric D-loop formation, possibly explaining 
how TRF2 promotes non-telomeric HR.  Finally, we report telomere repeat binding factor 1 (TRF1) 
promotes Rad51-mediated telomeric D-loop formation, which may facilitate HR-mediated replication 
fork restart and explain why TRF1 is required for efficient telomere replication. 
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CHAPTER 1: INTRODUCTION 
 
Telomeric DNA 
Telomeres constitute a nucleoprotein structure which protects the termini of the linear 
chromosomes present in virtually all eukaryotes from aberrant recognition as DNA damage and aberrant 
repair. At the level of primary sequence, telomeres consist of a repetitive or quasi-repetitive dsDNA tract 
of varying length. These dsDNA tracks often also possess ssDNA overhangs, most often of 3’ character, 
which may derive from either the end-replication problem or from elongation of the telomeres by 
recombination mediated methods or retrotranscription via the telomerase ribonuceloprotein complex 
(TERT). In mammals telomeres consist of a tract of 5’-GGTTAG-3’ repeat base paired with 
complimentary 5’-CTAACC-3’ repeats. This track can vary in length from several kilobasepairs (kbp) in 
length to in excess of 100 kbp. This variability in telomere length is affected by species, organism age, 
and due to disease or genetic factors. In humans telomere length varies from 5-15 kbp, and the telomeres 
possesses 3’ ssDNA tails of between 50 and 500 nt2. The terminal sequence of the 3’ tail is weakly 
defined with the plurality of ends terminating in a ‘TAG’ sequence3. The ss-to-dsDNA junction is more 
strictly defined, with the majority of ends possessing a terminal; ‘ATC’3. The length of the overhang and 
the end sequences appear to be specified by post-replicative processing of the telomeres3.  
 
 
Figure 1.1: Diagram of telomeric DNA. (A) The genomic portion of chromosomes are flanked by 5-15 
kbp of telomeric repeats that terminate in a 50-500 nt 3’ tail. (B) The 5’ and 3’ sequences are respectively 
strongly and weakly defined in vivo. The predominant sequences are shown. 
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Telomere Proteins 
 Telomeric dsDNA provides a binding site for two homologous human DNA binding proteins, 
telomere repeat-binding factors 1 and 24. While TRF2 is most often described as a telomeric dsDNA 
binding protein, considerable evidence exists which suggests the preferred binding site of TRF2 may be to 
the telomeric ss/dsDNA junction5-8. In addition to binding to telomeric dsDNA, TRF2 also interacts with 
an accessory protein, repressor-activator protein 1(RAP1) 9, 10. RAP1 plays poorly understood roles in 
mammalian telomere biology, but has been implicated in repressing repair processes at the telomere and 
perhaps to improving the binding specificity of TRF256. TRF1 and TRF2 also interact with a scaffolding 
protein, TRF2 interacting nuclear protein 1 (TIN2) 11. TIN2 in turn provides a binding site a bridging 
protein, TIN2 and POT1 Interacting Protein 1 (TPP1), 12 which stabilizes the binding of a telomere 
specific ssDNA bind protein, protection of telomeres 1 (POT1) 13.  
 
Figure 1.2: Telomere binding proteins. Telomere repeat binding factors 1 and 2 (TRF1 and 2) bind to 
telomeric dsDNA, with TRF2 binding preferentially to the ss/dsDNA junction. TRF2 also interacts with 
an accessory protein, repressor activator protein 1 (RAP1). TRF1 and TRF2 provide a binding site for a 
scaffolding protein, TRF2 interacting nuclear protein 2 (TIN2). TIN2 likewise permits binding of a 
telomeric ssDNA binding protein, protection of telomeres 1 (POT1), via its interaction with TIN2 and 
POT1 interacting protein 1 (TPP1, alternately known as TINT1, PTOP and PIP1). 
 
Homologous Recombination 
 Homologous recombination/repair is a multistep process that repairs double-strand breaks (DSB) 
with high fidelity, and which may promote the restart of stalled replication fork and the repair of 
numerous DNA lesions. The process of HR is incompatible with at-least one alternative repair process, 
non-homologous end joining (NHEJ), which repairs double-strand breaks in a lower-fidelity manner. The 
repair of a DSB via HR is initiated by the binding of the MRE11/Rad50/NBS1 (MRN) complex, which  
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promotes resection of the 5’ end of the DSB to generate a 3’ ssDNA tail vaguely similar in structure to the 
3’ tail of a telomere14. This ssDNA is rapidly bound by replication protein A ( RPA)15, but is subsequently 
displaced by Rad51, the recruitment of which is promoted by breast cancer associated gene 2 (BRCA2) at 
the ss/dsDNA junction16, 17. Rad51 then facilitates a process of homology search, whereby the ssDNA 
substrate interrogates available dsDNA for complimentary sequence18. Rad51 first forms a protein-
mediated complex between the substrate ssDNA and complimentary dsDNA and thereafter promotes 
protein-independent base pairing of the substrate and template in an ATP dependent manner generating a 
displacement loop (D-loop) within the template 18. Following displacement loop formation a variety of 
HR factors, including RecQ helicases such as Blooms (BLM) 19, 20 and Werner (WRN) 20 helicase, 
promote the migration and expansion of the D-loop and the eventual formation of a Holliday Junction 
(HJ) wherein both strands of the damaged substrate are paired with homologous sequences. These holiday 
junctions can then be cleaved or ‘resolved’ by HJ resolvases, such as the SLX1/4 complex, leaving behind 
two single-strand breaks (SSBs), which are then ligated21. 
 
Chromosome End Capping 
As mentioned above, the ends of linear chromosomes superficially resemble the structure of a 
resected double-strand break22. However, cells must prevent the aberrant recognition of their telomeres as 
double-strand breaks. Failure to prevent this recognition may result in the initiation of cell cycle arrest, 
which if left unresolved can prompt apoptosis or senescence. Additionally, aberrant recognition of the 
telomeres as DNA damage can elicit aberrant repair of the telomeres as DNA damage. Aberrant repair of 
telomeres often results in the formation of a dicentric chromosome via joining of two telomeres23. This 
presents an obstacle to chromosome segregation upon cell division, and can result in failed segregation or 
in chromosome breakage24. To prevent these undesirable processes, human telomeres are protected by a 
number of processes. Most importantly, TRF2 and its accessory protein RAP1, have been reported to 
inhibit the activation of telomere-bound DNA-PKcs, a critical step in NHEJ25. Likewise, TRF2 has been 
reported to inhibit activation of the ataxia telangiectasia mutated (ATM) kinase, which is required for the 
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activation of MRNs exonucleolytic activities26. However, the exact mechanism or mechanisms that 
mediate telomere protection or ‘capping’ in vivo remain only poorly understood and despite these 
processes it appears that unperturbed telomeres are transiently recognized as DNA damage during the cell 
cycle in spite of these processes27. 
 
Higher Order Telomere Structure 
It has been discovered that telomeres possesses a variety of unusual structures both at the level of 
primary sequence and the tertiary structure of the telomere nucleoprotein complex. The G-rich ssDNA tail 
can form an unusual secondary structure wherein four triguanosine tracts can form a quadruplex (G4) 
stabilized by a number of monovalent ions28. This property is suspected to affect the replication of 
telomeric DNA as well29. The C-rich complement of the G-rich strand of the telomeres is replicated 
discontinuously. As such, the G-rich strand is left transiently single-stranded, which may permit 
formation of G4 structures. These structures are likely to inhibit DNA replication directly by interfering 
with nucleotide addition and indirectly by promoting fork slipping. Accordingly, telomeres have been 
observed to be particularly difficult to replicate, and are prone to defects consistent with fork stalling and 
slipping30. It has also been observed that telomeres from a variety of species often adopt a lariat or loop-
like structure (T-loop)31-34, which appear to be stabilized by base pairing between the ssDNA tail and 
internal telomeric sequence. T-loops appear to be subject to cleavage by HJ resolvases, such as the 
SLX1/4 complex35, and resolution of T-loops is believed to result in the generation of extrachromosomal 
circular telomere DNAs (T-circles) 35. These T-circles are generated upon disruption of factors that may 
promote migration or dissociation of the D-loop or HJ that stabilizes the T-loop, such as RecQ helicases35, 
36 or the regulator of telomere length 1 (RTEL1) helicase35. T-circles are also observed to be highly 
abundant in cells with unusually long telomeres or telomeres that are maintained in a HR mediated and 
telomerase independent alternative pathway (ALT)37. While it has been suggested that T-circles may play 
a role in lengthening telomeres, either by re-incorporation to the telomeres or by priming rolling-circle 
replication, these hypotheses have not been demonstrated in human cells in vivo38. 
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Figure 1.3: Representative telomere loops reported in the literature. T-loops have been observed at 
the telomeres of a variety of only-distantly related species by a variety of groups31-34 using an assortment 
of techniques.  
 
 
DNA Repair at the Telomeres 
It has been paradoxically observed that telomere maintenance and protection require the activity 
of several DNA repair proteins.  In contrast to HR, which is initiated by the MRN complex, NHEJ is 
initiated by binding of the Ku heterodimer (Ku 70 & Ku 80) and its associated DNA dependent protein 
kinase catalytic subunit (DNA-PKcs). While TRF2 and Rap1 inhibit DNA-PKcs activation at telomeres, it 
has been observed that both Ku and DNA-PKcs are required for proper telomere maintenance.  Disrupting 
the expression of Ku or DNA-PKcs results in telomere shortening or aberrant telomere repair in a variety 
of mouse or human cell lines. This may be due to Ku’s interaction with TRF2 or WRN helicase, which 
may facilitate telomere protection. Alternately, the binding of Ku to telomeres may inhibit alternative 
DSB repair pathways when activation of DNA-PKcs is inhibited by the TRF2/Rap1 complex.                        
 Likewise, it has been reported the BRCA2 recruits Rad51 to telomeres in a cell-cycle dependent 
manner, and disruption of the expression of either of these proteins results in telomere maintenance 
defects. It has been suggested that this defect may be due a telomere replication defect, rather than a 
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defect in telomere protection or capping. However, disrupting the expression of BRCA2 or Rad51 results 
in aberrant telomere repair even in quiescent and non-dividing cells, suggesting that the HR pathway is 
also required for telomere replication. It has been suggested that HR proteins including Rad51 may 
facilitate the formation of the T-loop structure. Immunodepletion of either TRF2 or Rad51 from nuclear 
extracts ablated the ability of those extracts to promote telomeric displacement loop formation; a requisite 
step in T-loop formation. This activity can be recovered upon addition of purified Rad51 or TRF2 to the 
immunodepleted extracts. However, there is evidence that TRF2 may also inhibit HR mediated processes 
at telomeres of humanized yeast strains56.  
While these sundry DNA repair proteins are known to play some important role in telomere 
biology, the nature of that role remains poorly understood. Our data suggest that HR processes at the 
telomeres are differentially regulated by TRF1 and TRF2. Literature suggests that this differential 
regulation may also be influenced by a variety of post-translational modifications and are mediated by 
several different protein domains. Many of these domains remain incompletely characterized. As such our 
understanding the actual role or roles of DNA repair proteins in telomere maintenance and biology 
remains cursory at best.  
 
Telomeric Proteins and DNA Repair 
 Telomere proteins have also been observed to play a poorly understood role in DNA repair and 
maintenance both at telomeric and non-telomeric locations. The most well characterized proteins that 
have these paradoxical interactions are TRF1 and TRF2. TRF2 is rapidly phosphorylated in response to 
the induction of non-telomeric DSBs39. Inhibition of this phosphorylation results in impaired break repair, 
suggesting that TRF2 does in fact promote repair40.  Supporting this hypothesis, it has been observed that 
TRF2 is rapidly recruited to sites of non-telomeric double-strand breaks in a manner that is dependent 
upon an N-terminal domain rich in basic residues 41. While it has been suggested that this defect may arise 
due to impaired NHEJ, it may in fact be due to impaired HR. Overexpression of TRF inhibits NHEJ and 
promotes HR in vivo41. Likewise knockdown of TRF2 inhibits HR in vivo41. The data we present herein 
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suggests that the basic domain of TRF2 facilitates non-telomeric D-loop formation, a necessary initiating 
step in HR.  
 TRF1 has also been observed to facilitate telomere replication in vivo30 despite previous reports 
that TRF1 actually inhibits replication of telomeric DNA in vitro42. It is plausible that in vitro TRF1 
binding to telomeric DNA may pose an obstacle to DNA polymerase, which is alleviated by one or more 
factors in vivo. Supporting this hypothesis is has been observed that TRF1 is post-translationally modified 
(PTM) by replication complex associated proteins43-49. These PTMs reduce TRF1 binding affinity and 
may relieve the replication inhibition observed in an in vitro reconstituted replication reaction. Interesting 
these PTMs are inhibited in vivo by TIN243 and a component of the Fanconi Anemia pathway, 
FANCD246. This careful modulation of TRF1 binding may only transiently remove TRF1 from near the 
replication fork. The data we present herein suggests that retaining TRF1 near the replication fork may be 
advantageous. Telomeric DNA is prone to fork stalling and slipping. Fork stalling event can be mitigated 
or reversed in an HR dependent manner, and we report that TRF1 promoted Rad51-mediated telomeric D-
loop formation. This is a critical step in some models of HR mediated replication fork restart.  
 
Scope of Dissertation 
 Presented here in is an investigation of functional interactions between TRF1, TRF2 and Rad51 
in vitro (Chapter 2). This characterization will be the main focus of this dissertation, as this project 
constituted the bulk of my independent work in Dr. Griffith’s laboratory. Published data characterizing 
genome organization and capsid stability of adeno-associated virus (Chapter 3)50, and characterization of 
a guanosine centric mechanism of chaperone-mediated RNA folding (Chapter 4)51 are also described. 
Finally, unpublished data from a characterization of the DNA binding properties of hnRNP A1 and UP1 
are described in Chapter 5. This projects are presented secondarily, as they constitute collaborative work 
on which I was not a first author, or work which did not yield data of sufficient quality for publication.  
 Chapter 2 describes our discovery that TRF1 and TRF2 differentially modulate Rad51 mediated 
telomeric and non-telomeric D-loop formation. The most significant finding of this chapter is likely our 
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discovery that TRF2 inhibits Rad51-mediated telomeric D-loop formation. This finding appears to 
contradict previous nuclear extract work by the Karlseder lab27, 52, but may be supported by findings from 
Dr. Gilson’s lab that TRF2 inhibits HR-mediated processed at humanized yeast telomeres53. Our finding 
that TRF2ΔB promotes Rad51-mediated non-telomeric D-loop formation may explain how TRF2 can 
promote HR-mediated non-telomeric double-strand break repair41. Likewise, our finding that TRF1 
promotes Rad51-mediated telomeric D-loop formation may suggest that TRF1 promotes telomeric 
replication fork restart, explaining how TRF1 may promote telomere replication in vivo30 despite findings 
that TRF1 and TRF2 actually inhibit telomeric DNA replication in vitro42. 
 Chapter 3 describes a collaborative project between the Griffith and Asokan laboratories wherein 
a multidisciplinary approach was used to investigate the relative thermal stability of scAAV and ssAAV 
when loaded with genomes of varying lengths50. I assisted with numerous EM examinations of AAV 
genomer release following thermal denaturation. However, most of this data was not used in the final 
publication. Portions of this relevant unpublished data will be described in Chapter 3.  
 Chapter 4 describes a collaboration with the laboratory of Dr Kevin Weeks and his collaborators. 
We provided purified UP1 protein, which was used as a key control to determine whether the guanosine-
centric mechanism of chaperone-mediated RNA folding they identified when using the MuLV NC protein 
was a conserved feature of RNA chaperones.  
Chapter 5 describes EM studies aimed at examining telomeric DNA binding properties of hnRNP 
A1 and UP1. This project was not pursued due to our inability to find conditions in which hnRNP A1 
bound in a conformation or structure that was amenable to EM examination. 
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CHAPTER 2: TRF1 and TRF2 Differentially Modulate Rad51-Mediated Telomeric and Non-
Telomeric Displacement Loop Formation In Vitro1 
 
INTRODUCTION 
 Mammalian telomeres consist of 5-15 kilobase pairs (kbp) of TTAGGG repeats that terminate in 
a 50-200 nucleotide (nt) single-stranded DNA (ssDNA) 3’ tail.  The telomere repeats and the single-
stranded-to-double-stranded DNA (ss/dsDNA) junction provide a binding site for telomere-specific 
proteins that shelter telomeres from being recognized as DNA damage.  While these shelterin proteins 
may directly inhibit DNA damage signaling,1, 2 the presence of a DNA loop at the end of the telomeres (t-
loop) may also mediate telomere protection.  One shelterin component, telomere repeat-binding factor 2 
(TRF2), is required for t-loop formation in vivo,3 and can promote t-loop formation in vitro4 by 
facilitating a strand invasion reaction between the ssDNA tail and upstream dsDNA in a telomere.  
However, telomere protection also requires components of the homologous recombination/repair (HR) 
pathway, which may facilitate telomere replication or promote t-loop formation. 
 In vitro, telomeric replication forks are prone to slipping,5 and replication of telomeric DNA is 
inefficient6 and prone to defects consistent with fork stalling.7  In vivo fork stalling can be mitigated by 
proteins involved in the HR pathway.8  Accordingly, replication of telomeric DNA in vivo is sensitive to 
disruption of that pathway.  The BRCA2 tumor suppressor recruits the Rad51-recombinase to telomeres 
during replication, and disrupting the expression of either of these proteins results in telomere shortening 
and fragility.  These phenotypes are attenuated in cells possessing short telomeres and are exacerbated by 
chemical inhibition of DNA replication.9  As such it’s likely that these defects are due in part to a 
telomere replication defect. 
___________________________ 
 1The following chapter describes work done in collaboration with Dr. Griffith. I materially 
contributed to all work described in this chapter42. 
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 Disrupting the HR pathway in non-dividing cells results in aberrant telomere repair.  Therefore, it 
is likely that the HR pathway also contributes to telomere protection in a replication-independent 
manner,9 possibly by promoting t-loop formation.  Concordantly, both TRF2 and Rad51 are required for 
cell extracts to promote telomeric D-loop formation;10 a requisite step in t-loop formation.  Interestingly, 
this relationship appears to be bi-directional.  Overexpression of TRF2 promotes, while TRF2 knockdown 
inhibits HR in vivo.11  While these observations suggest that TRF2 and HR cooperate functionally in vivo, 
this hypothesis contradicts these proteins’ established in vitro activities.  TRF2 induces positive 
supercoiling within telomeric dsDNA upon binding,12 but Rad51 most efficiently promotes D-loop 
formation when acting upon negatively supercoiled dsDNA templates.13 
 To investigate functional interactions between shelterin proteins and the HR pathway, we 
undertook an in vitro characterization of the combined activities of purified proteins from these pathways.  
While the use of purified proteins permits an examination of their isolated functional interactions in vitro, 
such interactions may be affected by other proteins in vivo. The absence of such other proteins likely 
explains why the results of our assay contradict previous cell-extract based characterizations.10  We report 
that TRF2 inhibits the ability of Rad51 to promote telomeric D-loop formation, suggesting that Rad51 
does not promote t-loop formation and elucidating a novel mechanism by which TRF2 inhibits aberrant 
DNA repair at the telomeres.  In contrast, we report that TRF1 promotes Rad51-mediated telomeric D-
loop formation, possibly explaining why TRF1 is required for efficient telomere replication.  Finally, we 
report that a TRF2 mutant lacking the dsDNA binding domain was able to promote Rad51-mediated D-
loop formation, suggesting that one or more TRF2 domains can positively modulate Rad51 activity and 
possibly explaining how TRF2 can facilitate HR. 
 
MATERIALS AND METHODS 
DNA Substrates, Templates and Competitors 
 A pBluescript derived plasmid containing a 103 bp telomeric tract  (pBB: TTAGGG)17T) was 
generated by conventional cloning via insertion of the BsmBI/BbsI fragment of pRST154 into BsmBI cut 
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pRST15.  A pBluescript derived plasmid containing a non-telomeric insert  (pGL GAP) was generated as 
previously described.14  All plasmids were cultured in DH10B E. coli and purified using Qiagen Maxiprep 
kits.  HPLC purified 5’ Cy3 labeled G-rich telomeric 90 mer oligonucleotide (T90:[Cy3] (GGTTAG)15), 
D1 oligonucleotide 
([Cy3]AAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCA
GTGAGGCACCTATCTCAGCGATCTGTCTATTT) and T3 promoter primer  
([Cy3]ATTAACCCTCACTAAAGGA) and HPSF purified unlabeled T7 promoter primer  
(TAATACGACTCACTATAGGG) were ordered from Eurofins MWG Operon.  A 255 bp Cy3-labeled 
PCR product was amplified from pBB using the 5’ Cy3-labeled T3 and unlabeled T7 promoter primers 
and Q5 High Fidelity Polymerase (New England Biolabs) as per the manufacturer’s instructions and 
purified using a DNA Clean & Concentrator-25 column (Zymo Research). 
 
Proteins 
 Untagged Rad51 was expressed and purified as previous described15 from a pET-24 derived 
plasmid (EMD Millipore), which was generously provided by Dr.  Richard Fishel (Ohio State University, 
USA).  N-terminally hexahistidine tagged TRF2, TRF2∆B, TRF2∆M and TRF1 were purified from 
pTRC-HIS derived plasmids (Invitrogen) adapted from vectors generously provided by the laboratory of 
Dr.  Eric Gilson12  (University of Nice, France) or modified from vectors previously described.16  All 
TRF2 cDNAs were modified to include the Ala434 codon that is absent in HeLa derived TRF2 clones.17 
Briefly, a pTRC-HIS plasmid was transformed into BL21(DE3)PlysS E. coli and serially passaged to 
inoculate 1 L of Terrific Broth  (Sigma-Aldrich) containing 50 μg/ml ampicillin.  The culture was grown 
to an OD of 0.6 at 595 nm, and protein expression was then induced via addition of 1 mM Isopropyl β-D-
1-thiogalactopyranoside (Promega) for 4 h at 37°C.  The cells were then recovered via centrifugation, 
washed with phosphate buffered saline, resuspended in 100 ml of buffer containing 20 mM HEPES at pH 
7.5, 300 mM NaCl, 10% Glycerol, 0.5 mM DTT and 50 mM Imidazole supplemented with protease 
inhibitors  (Roche) and then flash frozen in liquid nitrogen.  The cells were then thawed and lysed via 
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sonication following addition of 1 mg/ml egg white lysozyme and 20 μL of RQ1 DNAse (Promega) and 
20 μL of RNAse A  (Sigma).  The crude lysate was then centrifuged in an SW-41 Ti rotor at 41,000 RPM 
for 1.5 h.  The supernatant was collected and serially purified over 1 ml HisTrap HP, HiTrap Heparin HP 
and HiTrap Q FF columns using an ÄKTApurifier FPLC (GE Bioscience).  Rad51, TRF2, TRF2∆B and 
TRF2∆M protein were recovered in 20 mM HEPES at pH 7.5, 150 mM NaCl, 10% Glycerol and 0.5 mM 
DTT,  while TRF1 was recovered in 20 mM HEPES at pH 7.5, 300 mM NaCl, 10% Glycerol, 0.5 mM 
DTT.  These proteins were aliquoted, flash frozen with liquid nitrogen and stored at -80°C until use.  
Protein concentration was determined using a Biorad Protein Assay calibrated against a Bovine Gamma 
Globulin standard set (Biorad).  For all proteins homogeneity was assessed as >90% by Coomassie 
staining of SDS-PAGE gels.  Immediately prior to use in experiments TRF2, TRF2∆B, TRF2∆M and 
TRF1 were diluted to a final concentration of 4.25 μM in buffer containing 19 mM HEPES-KOH, 203.8 
mM NaCl, 1 mM CaCl, 1 mM ATP, 7% glycerol, and 0.7 mM DTT.  All protein concentrations are 
reported as monomeric protein.  Rad51 was purified to a concentration of 27.5 μM and was used un-
diluted in all experiments.  Fraction V Bovine Serum Albumin (Fisher) was diluted to 10 mg/ml in 20 
mM potassium phosphate at pH 7.0, 50 mM NaCl, 5% Glycerol and 0.1 mM EDTA. 
 
Displacement Loop Assay 
 For the displacement loop assay 2.4 μM in nucleotides  (nt) of the 5’ Cy3 labeled telomeric 90 
mer  (26.67 nM Oligo) was incubated with no protein or 1,000-1,500 nM Rad51 at 37 °C for 10 min in a 
reaction buffer containing 5 mM HEPES-KOH at pH 7.5, 1 mM CaCl, 1 mM ATP, 0.8 mM DTT and 100 
μg/ml BSA.  Simultaneously, the pBB plasmid, 35 μM in base pairs (bp) or 10 nM plasmid was incubated 
with no protein or 100-500 nM TRF2, TRF2∆B, TRF2∆M or TRF1 at 37 °C for 10 min in reaction buffer 
and 100 μg/ml BSA.  Equal volumes of these reactions were then combined to give final Rad51 
concentrations of 0 or 500-750 nM and a final concentration of 0-250 nM TRF2, TRF2∆B, TRF2∆M or 
TRF1.  These reactions were incubated at 37 °C for 1 h then deproteinized via addition of 0.5% sodium 
dodecyl sulfate and 1 mg/ml Proteinase K (Ambion) and incubation at 37 °C for 15 min.  Glycerol 
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loading buffer  (5% Glycerol, 1.67 mM Tris, 0.17 mM EDTA, 0.017% SDS) was then added to 1X and 
the samples were separated for 30 min in a small-format 1% 1/2X TBE agarose gel at 100 V  (6.67 V/cm) 
in a light-protected box in a 4 °C cold room.  All figures are labeled with the final respective protein 
concentrations. 
Electrophoretic Mobility Shift and Binding Competition Assay 
 To demonstrate binding via an electrophoretic mobility shift assay, 2.55 μM in bp of the Cy3-
labeled PCR product  (10 nM product) was incubated with no protein or 100-500 nM TRF2, TRF2∆B, 
TRF2∆M or TRF1 at 37 °C for 10 min in reaction buffer supplemented with 100 μg/ml BSA.  To 
demonstrate binding specificity via a competition assay, an additional set of 500 nM reactions were 
performed in buffer containing no competitor or between a 1:1  (2.55 μM bp) and 200:1  (510 μM bp) 
excess of pGL GAP and then incubated at 37 °C for 25 min.  To demonstrate that the induced supershifts 
were protein-mediated a 500 nM reaction containing no competitor was incubated for 10 min then 
deproteinized with SDS and proteinase K for 15 min.  Glycerol loading buffer containing no SDS was 
then added to 1X and the samples were separated for 30 min in a small-format 1/2X TBE agarose gel at 
100 V (6.67 V/cm) in a light-protected box in a 4 °C cold room.  All figures are labeled with the final 
respective protein concentrations. 
 
Imaging 
 All Cy3 labeled gel products were imaged using a Biorad Typhoon Scanner equipped with a 532 
nM green laser module and a 580 nM bypass filter.  Gels were imaged with a photomultiplier setting of 
600 and a pixel size of 100 microns.  All gels were imaged with a +3 mm focal plane setting.  Gel image 
intensity was then adjusted using ImageQuant software (GE Life Sciences) and quantified using ImageJ 
software (NIH). 
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RESULTS 
A Fluorescent TRF2 and Rad51-Mediated Displacement Loop Assay  
 To investigate functional interactions between Rad51 and TRF2 we developed a fluorescent 
displacement loop (D-loop) assay (Fig. 2.1A) adapted from previous TRF2 and Rad51 
characterizations.12, 15 Untagged Rad51, and N-terminally hexahistidine tagged TRF1, TRF2 and TRF2 
mutant proteins lacking either the N-terminal basic domain of TRF2 (TRF2∆B) or the C-terminal Myb 
domain of TRF2  (TRF2∆M) were purified from E. coli to >90% homogeneity  (Supporting Information 
Fig. 2.S1).  In this assay co-incubation of a Cy3-labeled telomeric ssDNA substrate (T90) with a dsDNA 
telomeric plasmid template (pBB) in the absence of any proteins resulted in low-to-undetectable levels 
(<0.5%) of spontaneous D-loop formation (Fig. 2.1B, C: Lane 1).  In contrast, pre-incubation of the 
substrate with purified Rad51 protein prior to its addition to the template promoted D-loop formation in a 
Rad51-concentration dependent manner (Fig. 2.2A, B).  Likewise, pre-incubation of the template with full 
length TRF2 protein prior to its addition to the substrate could promote D-loop formation across a 
discreet range of TRF2 concentrations (Fig. 2.1B).  TRF2∆B exhibited only 47% of the activity of full-
length TRF2 (Table 2.1), but this residual activity was similarly optimal across a narrow range of 
concentrations (Fig. 2.1B).  In contrast, TRF2∆M and TRF1 respectively exhibited only 31% and 27% of 
the activity of full length TRF2 (Table 2.1), and were maximally active only at higher concentrations 
(Fig. 2.1C). 
 Rad51-mediated D-loop formation was observed to be homology driven.  Rad51 could promote 
D-loop formation between telomeric substrates and templates, and non-telomeric substrates and 
templates, but not between a telomeric substrate and a non-telomeric template (Supporting Information 
Fig. 2.S2A, B).  Under identical conditions, Rad51-mediated telomeric D-loop formation was 6.4 fold 
higher (Table 2.1) than non-telomeric D-loop formation (Supporting Information Fig. 2.S2).  This is 
consistent with previous characterizations showing that the activity of Rad51 is enhanced on repetitive 
and GT rich substrates.18, 19 In contrast to Rad51, TRF2-mediated D-loop formation was observed to be 
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critically dependent upon telomeric homology.  TRF2 could promote D-loop formation only between 
telomeric substrates and templates (Supporting Information Fig. 2.S2C, D). 
 
TRF2 Inhibits Rad51-Mediated Telomeric But Not Non-Telomeric D-Loop Formation.  
 To test for functional interactions between TRF2 and Rad51, D-loop assay reactions were 
prepared in which the template was pre-incubated with either a fixed concentration of TRF2 or no protein, 
while the substrate was pre-incubated with one of several concentrations of Rad51 or no protein prior to 
the combination of the substrate and template reactions.  Pre-incubation of a telomeric template with 
TRF2 reduced the ability of Rad51 to promote D-loop formation between the template and a homologous 
telomeric substrate by 52±5.1% (Table 2.1; Fig. 2.2A, B).  In contrast, TRF2 did not significantly inhibit 
Rad51-mediated non-telomeric D-loop formation (Table 2.1; Fig. 2.2C, D).  Taken together, these data 
suggested that TRF2 differentially modulates Rad51-mediated telomeric and non-telomeric D-loop 
formation. 
 
Figure 2.S1 Proteins Used.  (A) Diagram and partial domain map of hexahistidine tagged TRF1, TRF2, 
TRF2∆B and TRF2∆M compared against endogenous TRF2 (Q15554.2) and endogenous TRF1 
(NP_059523.2), partially adapted from40.  (B) Coomassie stained SDS-PAGE gel containing 2 μg of each 
of purified Rad51, TRF2, TRF2∆B, TRF2∆M, TRF1, and BSA. 
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Figure 2.1 TRF-mediated telomeric D-loop formation.  (A) Diagram of D-loop assay.  (B) TRF2 and TRF2∆B promote telomeric D-loop 
formation with an activity peak when included at a final concentration of between 100 nM (lane 3) and 150 nM (Lane 4) of protein.  (C) TRF2∆M 
and TRF1 promote telomeric D-loop formation only at higher concentrations. 
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Figure 2.2 TRF2 inhibits Rad51-mediated telomeric but not non-telomeric D-loop formation.  (A) Rad51 
promotes telomeric D-loop formation in a concentration dependent manner that is inhibited by TRF2.  (B) 
Quantification of data in (A).  (C) Rad51 promotes non-telomeric D-loop formation in a concentration 
dependent manner that is not affected by TRF2. (D) Quantification of data in (C).  (E) Diagram of DNA 
binding and competition assay.  (F) TRF2 binding supershifts the template into the wells.  This binding is 
specific and persists in the presence of high concentrations of non-telomeric competitor and is protein-
mediated.  Error bars shown 95% confidence interval, significant difference between +Buffer and +TRF2 
(*), paired samples t-test α=0.05 from three independent experiments.  
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Figure 2.S5 Area under the curve (AUC) calculation procedures (C% = Complex %).  (A) A 
representative activity trace from data shown in Figure 1C.  AUC is calculated as (Complex% × [TRF2] 
nM) for all regions of the activity trace.  (B) A representative activity trace from data shown in Figure 2A.  
AUC is calculated as (Complex% × [Rad51] nM) for 500-750 nM [Rad51].
Table 2.1 Properties of TRF2, TRF2∆B, TRF2∆M and TRF1 
 
 
 
 
 
 
Proteins 
TRF-Induced  
Telomeric  
D-Loop 
Formation  
 
AUC 0-250 nM 
% of TRF2 
Rad51-Mediated  
Telomeric  
D-loop Formation  
 
 
AUC 500-750 nM 
% Change From Buffer 
Rad51-Mediated 
 Non-Telomeric  
D-Loop Formation 
 
 
AUC 500-750 nM 
% Change From Buffer 
 
Telomeric 
DNA 
Binding  
 
 
 
C1/2, nM 
Telomeric 
Binding 
Specificity 
Migration 
in Agarose 
Gels 
 
Buffer† 
 
N/A 
30.3 ± 0.4 4.7 ± 0.4  
    N/A 
 
+ 
 
-         0 ± 0.7%       0 ± 7.6% 
 
TRF2 
  6.0 ± 0.15    13.3 ± 0.8 * 4.7 ± 0.0  
111 ± 8 
 
+ 
 
-   100 ± 2.4%        - 52 ± 5.1% *    + 4 ± 2.2% 
 
TRF2∆B 
2.8    22.1 ± 0.7 *  5.1 ± 0.7  
        257 
 
+ 
 
- 47%        - 31 ± 5.5% *    + 5 ± 7.2% 
 
TRF2∆M 
1.8 29.0 ± 1.4    9.6 ± 0.4 *  
        319 
 
- 
 
+ / - 31%      + 4 ± 4.0%     + 112 ± 13.0% * 
 
TRF1 
1.6    38.5 ± 1.9 *  5.4 ± 0.9  
     152 
 
+ 
 
+ 27%       + 25 ± 1.0% *    + 9 ± 5.2% 
†Buffer data are averaged.  Proteins are statistically compared against matched buffer controls. 
TRF-induced D-loop formation calculated as area under the curve (AUC: Complex% × [TRF] nM) from Figure 1. 
Rad51-mediated D-loop formation calculated as AUC (Complex% × [Rad51] nM) from Figures 2-5. 
AUC calculation examples in Figure 2.S5. 
C1/2 represents the concentration of TRF protein required to supershift 50% of template in EMSAs. 
Errors shown are 95% confidence intervals from three independent experiments.  
* denotes significant difference (p<0.05) from buffer via two-tailed paired samples t-test. 
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Figure 2.S2 TRF2-mediated D-loop formation requires telomeric homology while Rad51 does not.  (A) Rad51 promotes telomeric D-loop 
formation between pBB and T90 (top left), but not between pGL GAP and T90.  Rad51 can promote non-telomeric D-loop formation between D1 
and both pGL GAP and pBB.  (B) Quantification of (A).  (C) TRF2 promotes D-loop formation only between T90 and pBB.  (C) Quantification of 
(A).  (D) Quantification of (C). 
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 Rad51-mediated D-loop formation is a multi-step process initiated by Rad51 binding to ssDNA to 
form a nucleoprotein filament, which subsequently interrogates dsDNA for matching antisense sequence 
in a process known as ‘homology search’.  In this process a Rad51-coated substrate initially forms a 
protein-mediated complex with a homologous template.  Subsequently Rad51 promotes D-loop formation 
between the substrate and template.20  To determine what step or steps of this process might be inhibited 
by TRF2 we performed several order of addition experiments. 
 We observed that the ability of TRF2 to inhibit Rad51-mediated telomeric D-loop formation was 
dependent upon addition of TRF2 early in the D-loop reaction (Fig. 2.S3).  TRF2 could inhibit Rad51-
mediated telomeric D-loop formation when pre-incubated with the telomeric template (T0) or when added 
to a combined reaction prior to D-loop formation (T0+10min).  However, TRF2 could not inhibit Rad51-
mediated D-loop formation if added after D-loop formation had already occurred (T0+3hrs).  These 
observations suggested that TRF2 modulates Rad51-mediated D-loop formation via a passive mechanism, 
possibly by interfering with Rad51 filament formation, inhibiting homology search or by preventing 
subsequent D-loop formation. 
 We also observed that TRF2 could inhibit Rad51-mediated telomeric D-loop formation regardless 
of whether TRF2 was pre-incubated with the telomeric template or with the Rad51-coated substrate 
(Figure 2.S4).  However, the degree of this inhibition was reduced when TRF2 was incubated with the 
substrate compared with when it was incubated with the template.  This suggests that TRF2 does not 
inhibit Rad51 at the level of filament formation.  Instead, it appears that the ability of TRF2 to inhibit 
Rad51-mediated telomeric D-loop formation is dependent upon the ability of TRF2 to bind to or modify 
the template. 
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Figure 2.S3 TRF2 inhibits Rad51-mediated telomeric D-loop formation only when added early in D-loop reactions.  (A) Diagram of order of 
addition experiment.  (B)  TRF2 inhibits Rad51-mediated telomeric D-loop formation when added early in the reactions (T0 and T0+10min vs no 
TRF2) but not when added late in the reaction (T0+3hrs vs no TRF2).  (C) Quantification of (B), error bars shown 95% confidence intervals from 
three independent experiments.  (*) significant difference between indicated samples, paired samples t-test α=0.05.  (NS) No significant 
difference. 
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 To investigate whether the DNA binding activities of TRF2 mediate its ability to inhibit Rad51-
mediated telomeric D-loop formation, we characterized the binding affinity and specificity of TRF2 using 
an electrophoretic mobility shift assay (EMSA) and a binding competition assay (Fig. 2.2E).  Incubating a 
Cy3-labeled template containing a 103 base pair  bp telomere tract with increasing concentrations of 
TRF2 resulted in a supershift of the template, consistent with stable TRF2 binding  (Fig. 2.2F).  The 
binding to TRF2 to the template was observed to be specific, and persisted even in the presence of high 
concentrations of non-telomeric competitor  (Fig. 2.22F: lanes 8-11).  Nearly all low-mobility species 
generated by TRF2 binding became trapped in the wells.  This supershift was protein mediated, and could 
be disrupted by incubation with SDS and proteinase K (Fig. 2.2F: lane 12). 
 To further investigate possible mechanism by which TRF2 may inhibit Rad51-mediated telomeric 
D-loop formation we characterized the binding activity and the telomeric and non-telomeric Rad51-
modulating activities of a variety of TRF2 mutant proteins and TRF1, a close homolog of TRF2. 
 
TRF2∆M Promotes Rad51-Mediated Telomeric But Not Non-Telomeric D-Loop Formation.  
 The dsDNA binding activity of TRF2 is primarily directed by its C-terminal Myb domain.  
Deletion of this Myb domain reduces telomeric dsDNA binding affinity by a factor of 2.9 (Table 2.1), 
eliminates telomeric binding specificity and grossly alters DNA binding properties compared to full-
length TRF2 (Fig. 2.3E).12  Interestingly and in contrast to TRF2, TRF2∆M does not inhibit Rad51-
mediated telomeric D-loop formation (Table 2.1; Fig. 2.3A, B).  Also in contrast to TRF2, TRF2∆M was 
found to promote Rad51-mediated non-telomeric D-loop formation by 112±13.0% (Table 2.1; Fig. 2.3C, 
D).  Taken together these observations suggest that the Myb domain of TRF2 both contributes to the 
ability of TRF2 to inhibit Rad51-mediated telomeric D-loop formation and suppresses the ability of TRF2 
to promote Rad51-mediated non-telomeric D-loop formation. 
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Figure 2.3 TRF2∆M promotes Rad51-mediated non-telomeric but not telomeric D-loop formation.  (A) 
Rad51 promotes telomeric D-loop formation in a concentration dependent manner that is not affected by 
TRF2∆M.  (B) Quantification of data in (A).  (C) Rad51 promotes non-telomeric D-loop formation in a 
concentration dependent manner that is promoted by TRF2∆M.  (D) Quantification of data in (C).  (E) 
TRF2∆M binding supershifts the template into a lower mobility species and into the wells.  This binding 
is non-specific and is disrupted by low concentrations of non-telomeric competitor and is protein-
mediated.  Error bars shown 95% confidence interval, significant difference between +Buffer and 
+TRF2∆M (*), paired samples t-test α=0.05 from three independent experiments. 
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TRF2∆B Inhibits Telomeric But Not Non-Telomeric Rad51-Mediated D-Loop Formation.   
 In addition to its Myb domain, TRF2 possesses an N-terminal domain rich in basic residues that 
has been implicated in directing the binding of TRF2 to ss/dsDNA junctions and unusual DNA 
structures.4, 21 This domain also promotes the annealing and migration of DNA joints in a manner not 
unlike that required during D-loop formation.22  To investigate whether the basic domain of TRF2 
contributes to the ability of TRF2 to inhibit Rad51-mediated telomeric D-loop formation or the ability of 
TRF2∆M to promote Rad51-mediated non-telomeric D-loop formation we characterized the DNA 
binding affinity and specificity and Rad51-modulating activity of a TRF2 mutant protein lacking the basic 
domain of TRF2  (TRF2∆B). 
 Like TRF2 and in contrast to TRF2∆M, TRF2∆B was found to inhibit Rad51-mediated telomeric 
D-loop formation by 31±5.5% (Table 1; Fig. 2.4A, B), suggesting that the joint-binding activity of TRF2 
is not required for TRF2 to inhibit Rad51-mediated telomeric D-loop formation.  In contrast, TRF2∆B 
was not observed to affect Rad51-mediated non-telomeric D-loop formation (Table 2.1; Fig. 2.4C, D).  
Deletion of the basic domain resulted in an approximately 2.3-fold reduction in template binding affinity 
(Table 1) but did not reduce binding specificity (Fig. 2.4E: lanes 8-11) compared to full length TRF2.  
Like TRF2, TRF2∆B binding resulted in the template becoming trapped in the wells. 
 
TRF1 Promotes Rad51-Mediated Telomeric But Not Non-Telomeric D-Loop Formation.  
 Our observation that TRF2 and TRF2∆B but not TRF2∆M could inhibit Rad51-mediated 
telomeric D-loop formation suggested that this inhibition could simply be due to Myb-domain directed 
dsDNA binding.  To test this hypothesis we characterized the DNA binding and Rad51-modulating 
activity of TRF1, a TRF2 homolog with a highly similar Myb domain (Supporting Information Fig. 
2.S1A).23  Interestingly and in contrast to TRF2, TRF1 was found to promote Rad51-mediated telomeric 
D-loop formation by 25±1.0% (Table 2.1; Fig. 2.5A, B), suggesting that the ability of TRF2 to inhibit this 
process is not simply due to Myb domain binding.  In contrast, TRF1 was found not to affect Rad51-
mediated non-telomeric D-loop formation (Fig. 2.5C, D).  Comparisons between TRF1 and TRF2 must  
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Figure 2.4 TRF2∆B promotes Rad51-mediated telomeric but not non-telomeric D-loop formation.  (A) 
Rad51 promotes telomeric D-loop formation in a concentration dependent manner that is promoted by 
TRF2∆B.  (B) Quantification of data in (A).  (C) Rad51 promotes non-telomeric D-loop formation in a 
concentration dependent manner that is not affected by TRF2∆B.  (D) Quantification of data in (C).  (E) 
TRF2∆B binding supershifts the template into the wells.  This binding is specific and persists in the 
presence of high concentrations of non-telomeric competitor and is protein-mediated.  Error bars shown 
95% confidence interval, significant difference between +Buffer and +TRF2∆B (*), paired samples t-test 
α=0.05 from three independent experiments. 
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Figure 2.5 TRF1 promotes Rad51-mediated telomeric but not non-telomeric D-loop formation.  (A) 
Rad51 promotes telomeric D-loop formation in a concentration dependent manner that is promoted by 
TRF1.  (B) Quantification of data in (A).  (C) Rad51 promotes non-telomeric D-loop formation in a 
concentration dependent manner that is not affected by TRF1.  (D) Quantification of data in (C).  (E) 
TRF1 binding supershifts the template into several low-mobility species.  This binding is specific and 
persists in the presence of high concentrations of non-telomeric competitor and is protein-mediated.  Error 
bars shown 95% confidence interval, significant difference between +Buffer and +TRF1 (*), paired 
samples t-test α=0.05 from three independent experiments.  
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be made with caution, as despite possessing comparable DNA binding affinity and telomeric sequence 
specificity (Table 2.1) their binding behavior is otherwise grossly different when examined in an EMSA.  
Whereas TRF2 binding shifts a telomeric template into the wells (Fig. 2.2F), TRF1 binding shifts the 
species into increasingly larger complexes as the TRF1 concentration is increased (Fig. 2.5E).  This 
behavior is perhaps consistent with previous observations that while TRF2 binds to telomeric dsDNA as a 
large oligomeric structure, TRF1 binds as a smaller complex.24, 25 Likewise, this property may be 
consistent with observations that TRF2 can promote the formation of unusual DNA structures and induce 
topological changes within telomeric DNA to a greater degree than TRF1.12, 26 
 
DISCUSSION 
 The results of this study suggest a model whereby TRF1 and TRF2 differentially regulate Rad51-
mediated telomeric and non-telomeric D-loop formation.  This would promote efficient telomeric DNA 
replication and non-telomeric HR while inhibiting aberrant HR at the telomeres.  TRF1 promotes Rad51 
mediated telomeric D-loop formation, which may facilitate replication fork restart and explain why TRF1 
is required for efficient telomere replication.  In contrast, TRF2 potently inhibits Rad51-mediated 
telomeric D-loop formation, providing yet another mechanism by which TRF2 can inhibit DNA repair at 
telomeres.  Finally, TRF2∆M promotes Rad51-mediated D-loop formation, providing insight into how 
TRF2 may contribute to HR.  Our findings are generally in good agreement with previous 
characterizations, and what contradictions exist are likely due to methodological differences. 
 Data from our in vitro characterization must be compared with other in vivo and genetic 
characterizations with caution.  The activities of TRF1, TRF2, and Rad51 are modulated in vivo by a 
variety of other proteins, including other shelterin and HR proteins, which are absent from our assay.  
Additionally, the templates and substrates used in our assay are necessarily different from their in vivo 
analogs.  The 3’ tails of telomeres are adjacent to a ss/dsDNA junction, which were absent from the 
substrates used in this work.  Furthermore, telomeres are several kbp in length, whereas our template 
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possesses only a 103 bp telomeric tract.  Finally, while the topology of telomeric DNA in vivo is 
unknown, the templates used in our assay were negatively supercoiled. 
 While we observed that TRF2 inhibits Rad51, it has previously been reported that TRF2 and 
Rad51 appear to exhibit functional cooperation.  Immunodepletion of TRF2 or Rad51 from cell extracts 
ablates the ability of those extracts to promote telomeric D-loop formation.10  Moreover, supplementation 
of such immunodepleted extracts with purified Rad51 or TRF2 can restore telomeric D-loop formation.10, 
27 However, the presence of factors in vivo that are absent from our in vitro characterization may affect 
the activities of TRF2 and Rad51. 
 Although TRF1 and TRF2 can be found at telomeres throughout the cell cycle and TRF1 
promotes efficient telomeric replication,7 TRF1 and TRF2 inhibit DNA replication in vitro.6  However, 
TRF1 and TRF2 binding are inhibited by post–translational modifications (PTMs), some of which are 
conferred by replication-complex associated proteins.28-34 
 These proteins may facilitate replication by transiently removing TRF1 and TRF2 from telomeric 
DNA near the replication fork.30  Interestingly, PTMs that reduce TRF1 binding are inhibited in vivo by 
another shelterin protein, TIN2,28 and by FANCD2, a component of the Fanconi anemia pathway.31  
Comparable PTMs of TRF2 are not likewise inhibited.  However, these TRF2 PTMs likely disrupt TRF2 
dimerization, which would be expected to abrogate Myb domain binding but that may not affect basic 
domain binding.  As TRF1 can promote and TRF2 can inhibit Rad51-mediated telomeric D-loop 
formation, the depletion of TRF2 but not TRF1 from DNA near the replication fork may facilitate HR-
mediated fork restart within the telomeres (Fig. 2.6A).  This process may also be facilitated by basic-
domain mediated recruitment of TRF2 to regressed forks, where it can both protect the nascent Holliday 
junction  (HJ) from HJ resolvases22 and recruit RecQ helicases that can promote fork migration.35, 36  
Likewise, the presence of TRF2 on telomeric dsDNA away from the fork may prevent HR-mediated 
strand invasion reactions and protect the telomeres from aberrant repair (Fig. 2.6B). 
 The role of TRF2 in the HR pathway, especially in non-telomeric contexts, is not well 
understood.  TRF2 is rapidly recruited to genomic dsDNA breaks (DSBs) and this recruitment requires 
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the basic domain of TRF2 but not its Myb-domain37 and can occur in an ATM deficient background.  
Additionally, TRF2 is phosphorylated by ATM38 in response to DNA damage,39 and mutations that 
disrupt TRF2 phosphorylation inhibit DNA repair.40  While it has been suggested that this DNA repair 
defect may be due to impaired non-homologous end joining  (NHEJ),39 the defect may also be due to 
impaired HR.  Overexpression of TRF2 and TRF2∆M promote HR in vivo.11  Likewise, knockdown of 
TRF2 inhibits HR but not NHEJ in vivo.11  Our finding that TRF2∆M can promote Rad51-mediated D-
loop formation suggests a novel mechanism by which TRF2 can promote HR (Fig. 2.6C).  Upon 
induction of a DSB, TRF2 may undergo basic-domain mediated recruitment to the site of damage.  TRF2 
may then help recruit proteins such as the Mre11/Rad50/Nbs1  (MRN) complex,41 which promotes end 
resection in preparation for HR.  Following end resection, Rad51 binding and homology search, the basic 
domain of TRF2 may facilitate Rad51-mediated D-loop formation by promoting the opening of the 
template dsDNA in a manner similar to a Rad51 accessory protein, Rad54.13 
 This model of the interaction of TRF1, TRF2 and Rad51 provides insight into both telomere 
biology and the HR pathway.  Previous characterizations suggested that TRF2 and Rad51 cooperate to 
promote telomeric D-loop and possibly t-loop formation in vivo, despite apparent incompatibilities in the 
in vitro activities of these proteins.  Our finding that TRF2 inhibits Rad51-mediated telomeric D-loop 
formation suggests that Rad51 does not contribute to t-loop formation, or that this inhibition must be 
alleviated by additional factors in vivo.  While it has previously been reported that TRF1 is required for 
efficient telomere replication, this requirement seems at odds with other reports that TRF1 can inhibit 
telomere replication.  Our finding that TRF1 promotes Rad51-mediated telomeric D-loop formation 
suggests that TRF1 may facilitate telomere replication by promoting HR-mediated replication fork restart.  
Finally, our observation that TRF2∆M can promote Rad51-mediated non-telomeric D-loop formation 
may explain how TRF2 can promote HR in vivo. 
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Figure 2.6 TRF1 and TRF2 differentially modulate Rad51-mediated telomeric and non-telomeric D-loop 
formation.  (A) Post translational modifications may deplete TRF2 but not TRF1 from telomeric DNA 
near a replication fork, possibly by inhibiting TRF2 Myb domain binding.  Following fork collapse, basic 
domain directed TRF2 binding can protect regressed forks from cleavage and recruit factors that promote 
fork migration.  Finally, TRF1 can promote D-loop formation away from the fork and thereby promote 
HR mediated fork restart.  (B) TRF2 inhibits Rad51-mediated telomeric D-loop formation, which may 
prevent aberrant repair processes at the telomeres.  (C) TRF2 is recruited to DSBs, where it may promote 
recruitment of enzymes that promote end resection.  Afterwards, the basic domain of TRF2 may promote 
Rad51-mediated D-loop formation and thereby promote HR. 
 
 
 
 
 
 
 
 
 
 
35 
 
REFERENCES 
 
[1] Bombarde, O., Boby, C., Gomez, D., Frit, P., Giraud-Panis, M. J., Gilson, E., Salles, B., and Calsou, 
P. (2010) TRF2/RAP1 and DNA-PK mediate a double protection against joining at telomeric 
ends, EMBO J 29, 1573-1584. 
 
[2] Karlseder, J., Hoke, K., Mirzoeva, O. K., Bakkenist, C., Kastan, M. B., Petrini, J. H., and de Lange, T. 
(2004) The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent 
DNA damage response, PLoS Biol 2, E240. 
 
[3] Doksani, Y., Wu, J. Y., de Lange, T., and Zhuang, X. (2013) Super-resolution fluorescence imaging of 
telomeres reveals TRF2-dependent T-loop formation, Cell 155, 345-356. 
 
[4] Stansel, R. M., de Lange, T., and Griffith, J. D. (2001) T-loop assembly in vitro involves binding of 
TRF2 near the 3' telomeric overhang, EMBO J 20, 5532-5540. 
 
[5] Fouche, N., Ozgur, S., Roy, D., and Griffith, J. D. (2006) Replication fork regression in repetitive 
DNAs, Nucleic Acids Res 34, 6044-6050. 
 
[6] Ohki, R., and Ishikawa, F. (2004) Telomere-bound TRF1 and TRF2 stall the replication fork at 
telomeric repeats, Nucleic Acids Res 32, 1627-1637. 
 
[7] Sfeir, A., Kosiyatrakul, S. T., Hockemeyer, D., MacRae, S. L., Karlseder, J., Schildkraut, C. L., and de 
Lange, T. (2009) Mammalian telomeres resemble fragile sites and require TRF1 for efficient 
replication, Cell 138, 90-103. 
 
[8] North, J. A., Amunugama, R., Klajner, M., Bruns, A. N., Poirier, M. G., and Fishel, R. (2013) ATP-
dependent nucleosome unwrapping catalyzed by human RAD51, Nucleic Acids Res 41, 7302-
7312. 
 
[9] Badie, S., Escandell, J. M., Bouwman, P., Carlos, A. R., Thanasoula, M., Gallardo, M. M., Suram, A., 
Jaco, I., Benitez, J., Herbig, U., Blasco, M. A., Jonkers, J., and Tarsounas, M. (2010) BRCA2 acts 
as a RAD51 loader to facilitate telomere replication and capping, Nat Struct Mol Biol 17, 1461-
1469. 
 
[10] Verdun, R. E., and Karlseder, J. (2006) The DNA damage machinery and homologous recombination 
pathway act consecutively to protect human telomeres, Cell 127, 709-720. 
 
[11] Mao, Z., Seluanov, A., Jiang, Y., and Gorbunova, V. (2007) TRF2 is required for repair of 
nontelomeric DNA double-strand breaks by homologous recombination, Proc Natl Acad Sci U S 
A 104, 13068-13073. 
 
[12] Amiard, S., Doudeau, M., Pinte, S., Poulet, A., Lenain, C., Faivre-Moskalenko, C., Angelov, D., 
Hug, N., Vindigni, A., Bouvet, P., Paoletti, J., Gilson, E., and Giraud-Panis, M. J. (2007) A 
topological mechanism for TRF2-enhanced strand invasion, Nat Struct Mol Biol 14, 147-154. 
 
[13] Sigurdsson, S., Van Komen, S., Petukhova, G., and Sung, P. (2002) Homologous DNA pairing by 
human recombination factors Rad51 and Rad54, J Biol Chem 277, 42790-42794. 
 
[14] Subramanian, D., and Griffith, J. D. (2005) p53 Monitors replication fork regression by binding to 
"chickenfoot" intermediates, J Biol Chem 280, 42568-42572. 
36 
 
[15] Amunugama, R., He, Y., Willcox, S., Forties, R. A., Shim, K. S., Bundschuh, R., Luo, Y., Griffith, 
J., and Fishel, R. (2012) RAD51 protein ATP cap regulates nucleoprotein filament stability, J 
Biol Chem 287, 8724-8736. 
 
[16] Smogorzewska, A., Karlseder, J., Holtgreve-Grez, H., Jauch, A., and de Lange, T. (2002) DNA 
ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2, Curr Biol 12, 
1635-1644. 
 
[17] Broccoli, D., Smogorzewska, A., Chong, L., and de Lange, T. (1997) Human telomeres contain two 
distinct Myb-related proteins, TRF1 and TRF2, Nat Genet 17, 231-235. 
 
[18] Biet, E., Sun, J., and Dutreix, M. (1999) Conserved sequence preference in DNA binding among 
recombination proteins: an effect of ssDNA secondary structure, Nucleic Acids Res 27, 596-600. 
 
[19] Tracy, R. B., Baumohl, J. K., and Kowalczykowski, S. C. (1997) The preference for GT-rich DNA 
by the yeast Rad51 protein defines a set of universal pairing sequences, Genes Dev 11, 3423-
3431. 
 
[20] Forget, A. L., and Kowalczykowski, S. C. (2010) Single-molecule imaging brings Rad51 
nucleoprotein filaments into focus, Trends Cell Biol 20, 269-276. 
 
[21] Fouche, N., Cesare, A. J., Willcox, S., Ozgur, S., Compton, S. A., and Griffith, J. D. (2006) The 
basic domain of TRF2 directs binding to DNA junctions irrespective of the presence of TTAGGG 
repeats, J Biol Chem 281, 37486-37495. 
 
[22] Poulet, A., Buisson, R., Faivre-Moskalenko, C., Koelblen, M., Amiard, S., Montel, F., Cuesta-Lopez, 
S., Bornet, O., Guerlesquin, F., Godet, T., Moukhtar, J., Argoul, F., Declais, A. C., Lilley, D. M., 
Ip, S. C., West, S. C., Gilson, E., and Giraud-Panis, M. J. (2009) TRF2 promotes, remodels and 
protects telomeric Holliday junctions, EMBO J 28, 641-651. 
 
[23] Court, R., Chapman, L., Fairall, L., and Rhodes, D. (2005) How the human telomeric proteins TRF1 
and TRF2 recognize telomeric DNA: a view from high-resolution crystal structures, EMBO Rep 
6, 39-45. 
 
[24] Poulet, A., Pisano, S., Faivre-Moskalenko, C., Pei, B., Tauran, Y., Haftek-Terreau, Z., Brunet, F., Le 
Bihan, Y. V., Ledu, M. H., Montel, F., Hugo, N., Amiard, S., Argoul, F., Chaboud, A., Gilson, E., 
and Giraud-Panis, M. J. (2012) The N-terminal domains of TRF1 and TRF2 regulate their ability 
to condense telomeric DNA, Nucleic Acids Res 40, 2566-2576. 
 
[25] Khan, S. J., Yanez, G., Seldeen, K., Wang, H., Lindsay, S. M., and Fletcher, T. M. (2007) 
Interactions of TRF2 with model telomeric ends, Biochem Biophys Res Commun 363, 44-50. 
[26] Yoshimura, S. H., Maruyama, H., Ishikawa, F., Ohki, R., and Takeyasu, K. (2004) Molecular 
mechanisms of DNA end-loop formation by TRF2, Genes Cells 9, 205-218. 
 
[27] Verdun, R. E., Crabbe, L., Haggblom, C., and Karlseder, J. (2005) Functional human telomeres are 
recognized as DNA damage in G2 of the cell cycle, Mol Cell 20, 551-561. 
 
[28] Smith, S., and de Lange, T. (2000) Tankyrase promotes telomere elongation in human cells, Curr 
Biol 10, 1299-1302. 
 
37 
 
[29] Ye, J. Z., and de Lange, T. (2004) TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere 
length control complex, Nat Genet 36, 618-623. 
 
[30] Beneke, S., Cohausz, O., Malanga, M., Boukamp, P., Althaus, F., and Burkle, A. (2008) Rapid 
regulation of telomere length is mediated by poly(ADP-ribose) polymerase-1, Nucleic Acids Res 
36, 6309-6317. 
 
[31] Lyakhovich, A., Ramirez, M. J., Castellanos, A., Castella, M., Simons, A. M., Parvin, J. D., and 
Surralles, J. (2011) Fanconi anemia protein FANCD2 inhibits TRF1 polyADP-ribosylation 
through tankyrase1-dependent manner, Genome Integr 2, 4. 
 
[32] Dantzer, F., Giraud-Panis, M. J., Jaco, I., Ame, J. C., Schultz, I., Blasco, M., Koering, C. E., Gilson, 
E., Menissier-de Murcia, J., de Murcia, G., and Schreiber, V. (2004) Functional interaction 
between poly(ADP-Ribose) polymerase 2 (PARP-2) and TRF2: PARP activity negatively 
regulates TRF2, Mol Cell Biol 24, 1595-1607. 
 
[33] Simbulan-Rosenthal, C. M., Rosenthal, D. S., Boulares, A. H., Hickey, R. J., Malkas, L. H., Coll, J. 
M., and Smulson, M. E. (1998) Regulation of the expression or recruitment of components of the 
DNA synthesome by poly(ADP-ribose) polymerase, Biochemistry 37, 9363-9370. 
 
[34] Walker, J. R., and Zhu, X. D. (2012) Post-translational modifications of TRF1 and TRF2 and their 
roles in telomere maintenance, Mech Ageing Dev 133, 421-434. 
 
[35] Machwe, A., Xiao, L., and Orren, D. K. (2004) TRF2 recruits the Werner syndrome (WRN) 
exonuclease for processing of telomeric DNA, Oncogene 23, 149-156. 
 
[36] Opresko, P. L., von Kobbe, C., Laine, J. P., Harrigan, J., Hickson, I. D., and Bohr, V. A. (2002) 
Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome 
helicases, J Biol Chem 277, 41110-41119. 
 
[37] Bradshaw, P. S., Stavropoulos, D. J., and Meyn, M. S. (2005) Human telomeric protein TRF2 
associates with genomic double-strand breaks as an early response to DNA damage, Nat Genet 
37, 193-197. 
 
[38] Tanaka, H., Mendonca, M. S., Bradshaw, P. S., Hoelz, D. J., Malkas, L. H., Meyn, M. S., and Gilley, 
D. (2005) DNA damage-induced phosphorylation of the human telomere-associated protein 
TRF2, Proc Natl Acad Sci U S A 102, 15539-15544. 
 
[39] Huda, N., Abe, S., Gu, L., Mendonca, M. S., Mohanty, S., and Gilley, D. (2012) Recruitment of 
TRF2 to laser-induced DNA damage sites, Free Radic Biol Med 53, 1192-1197. 
 
[40] Huda, N., Tanaka, H., Mendonca, M. S., and Gilley, D. (2009) DNA damage-induced 
phosphorylation of TRF2 is required for the fast pathway of DNA double-strand break repair, 
Mol Cell Biol 29, 3597-3604. 
 
[41] Zhu, X. D., Kuster, B., Mann, M., Petrini, J. H., and de Lange, T. (2000) Cell-cycle-regulated 
association of RAD50/MRE11/NBS1 with TRF2 and human telomeres, Nat Genet 25, 347-352. 
 
[42] Bower, B. D., and Griffith, J. D. (2014) TRF1 and TRF2 Differentially Modulate Rad51-Mediated 
Telomeric and Nontelomeric Displacement Loop Formation in Vitro, Biochemistry 53, 5485-
5495.  
38 
 
 
 
 
 
 
Chapter 3: Biophysical and Ultrastructural Characterization of Adeno-Associated Virus Capsid 
Uncoating and Genome Release1 
 
INTRODUCTION 
Adeno-associated virus (AAV) is a small (25 nm) nonenveloped virus belonging to the family 
Parvoviridae and genus Dependovirus. The AAV capsid packages a single-stranded (ssDNA) genome 
approximately 4.7 kb in length1. The wild-type genome consists of two open reading frames flanked by 
two inverted terminal hairpin repeats (ITRs). The ITRs, which are 145 nucleotides each, are the only cis 
element in the AAV genome required for successful packaging2,3. The AAV capsid is composed of 60 (T 
= 1) viral protein subunits VP1, VP2, and VP3, in approximately the ratio 1:1:10. The three different 
subunits are generated from overlapping reading frames and interact within the capsid through the 
common VP3 subunit region. The largest VP1 subunit is known to possess a phospholipase A2 domain 
required for infectivity4. Because of its broad tropism, lack of pathogenicity, and flexibility in genome 
content, AAV has become a promising candidate for therapeutic gene transfer applications. In the past 2 
decades, AAV has been utilized as a gene transfer vector in a number of phase I and phase II clinical 
trials treating various genetic diseases5. 
Different AAV serotypes infect cells by engaging a variety of cell surface glycans and 
coreceptors, followed by endocytic uptake4,6,7. Viral particles are then thought to escape from the 
endosome and translocate to the nucleus, where the ssDNA genome is released and undergoes second-
strand synthesis. Engineered AAV genomes containing a mutant 3′ ITR have been shown to package 
dimeric, self-complementary DNA (scDNA)8. Such scAAV vectors have the advantage of escaping 
ssDNA degradation9 and bypassing second-strand synthesis, which is a rate-limiting step preceding  
________________________ 
 1The following chapter describes work done in collaboration with Dr. Eric Horowitz, Dr. Shefaet 
Rahman, Dr. David Dismuke, Dr. Michael Falvo, Dr. Jack Griffith, Dr. Stephen Harvey, and Dr. Aravind 
Asokan. I significantly contributed to EM analysis of AAV genome release via thermal denaturation47. 
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transgene expression by AAV vectors10,11. These features have been shown to enable rapid onset of 
transgene expression by scAAV vectors. 
The packaging capacity of ssAAV and scAAV vectors has been extensively studied12-17. 
However, little is known about the consequences of packaging subgenomic-length DNA or self-
complementary genomes for AAV capsid uncoating. Previously, studies with minute virus of mice 
(MVM) packaging subgenomic-length DNA have demonstrated that such defective particles do not 
release their genomes in vitro18. Along with the observation that the MVM genome reinforces and 
increases the stiffness of MVM capsids19, these studies suggest that the viral genome exerts an internal 
pressure on the walls of the capsid, which is critical for proper capsid uncoating. Thermal analysis has 
previously been used to understand large conformational changes in AAV capsids such as exposure of the 
buried phospholipase A2 domain during infection18,20-22. In the current study, we utilized atomic force 
microscopy (AFM), electron microscopy (EM), and fluorescence-based assays to characterize the 
biophysical and ultrastructural properties of different AAV vectors and the impact of thermal stimuli on 
capsid uncoating/genome release. In addition, we utilized computational modeling and molecular 
dynamics (MD) to further understand the potential organization and architecture of DNA packaged within 
ssAAV and scAAV vectors. 
 
MATERIALS AND METHODS 
Chemicals and reagents 
Mica was purchased (Ted Pella Inc.) and cleaved immediately prior to use. Four-hundred-mesh 
copper Formvar carbon-coated TEM grids (Ted Pella Inc.) were made hydrophilic by glow discharge 
immediately before use. Uranyl acetate (Ted Pella Inc.) was used as received. Uranyl acetate solutions 
were centrifuged for several minutes prior to use to remove any precipitate or aggregates. SYBR gold 
(Invitrogen Life Sciences) was first diluted in water immediately prior to use. Tris-HCl and spermidine 
(ThermoFisher) were utilized as received. 
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Virus production and purification 
All viral vectors were generated at the UNC Vector Core by iodixanol gradient 
ultracentrifugation followed by ion-exchange chromatography and vector genome titers determined by 
dot blot assay as well as verified by quantitative PCR (qPCR) as described previously23. Single-stranded 
AAV serotype 2 vectors packaging different transgene cassettes were as follows: wild-type AAV genome 
containing rep and cap genes (4.7 kb)24, chicken β-actin (CBA) promoter-driven firefly luciferase (4.1 
kb)25, CBA promoter-driven tdTomato (3.8 kb)25, cytomegalovirus (CMV) promoter-driven firefly 
luciferase (3.6 kb)26, CMV promoter-driven green fluorescent protein (GFP) (3.4 kb)23, and an EF1a 
promoter-driven mCherry with an internal ribosome entry site (IRES) signal followed by WGA-Cre (5.3 
kb) 27. Self-complementary AAV2 vectors utilized in the study were as follows: CMV promoter-driven 
green fluorescent protein with lambda phage genome stuffer DNA (5.0 kb)23, CMV promoter-driven 
green fluorescent protein (4.6 kb)28, and CBA hybrid promoter-driven green fluorescent protein (4.1 kb)28. 
 
AFM 
Freshly cleaved mica was treated with 50 μl of polylysine (50 μg/ml) for 2 h at 37°C in a humid 
chamber. Mica was then washed three times with distilled water (dH2O) and dried. Viral particles (1 × 
1010 vector genomes [vg]) in 1× phosphate-buffered saline (PBS) were heated in a thermocycler for 30 
min to 37 or 65°C, followed by immediate chilling to 4°C. AAV was then deposited on the treated mica 
surface (10 μl) in a humid chamber for 45 min at room temperature. Mica pieces were then washed three 
times with dH2O and gently air dried. Atomic force microscopy (AFM) images were acquired using an 
Asylum MFP3D atomic force microscope. All images were collected in air using the tapping mode. 
Images were then processed using the MFP3D software. 
 
TEM 
Viral particles (2 × 1010 vg) in 1× PBS were heated in a thermocycler for 30 min to 37, 55, or 
65°C, followed by immediate chilling to 4°C. Vectors were then adsorbed onto 400-μm mesh carbon-
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coated copper transmission electron microscopy (TEM) grids for 2 min. After washing twice with 0.2-
μm-filtered dH2O, the grids were stained with freshly prepared 2% uranyl acetate for 30 s. After drying, 
grids were imaged using a Zeiss LEO 910 transmission electron microscope. Ten to 20 images of each 
grid were captured in random locations to get an accurate sampling of the viral particles. Each image was 
then analyzed using ImageJ by counting the number of full particles based on their distinct morphologies 
and intensity of uranyl acetate staining. Particle counts for each virus and experiment ranged from 395 to 
5,317 total particles. In all cases, the average and standard deviation for each temperature were 
determined using the percentage of full particles from each image. Empty particles determined by their 
differential staining29 were excluded from counting due to the presence of fragmented capsids and diverse 
morphology. 
 
Fluorometric assay for detection of thermally induced genome release 
Viral vectors (1 × 1010vg) in 1× PBS with 25 μM SYBR gold were heated using a Roche 
LightCycler 480. Samples were heated in a stepwise manner (2°C steps) from 37°C to 95°C. Viruses were 
held at each temperature for 5 min prior to measuring fluorescence. Each sample was subjected to thermal 
treatment in triplicate. In addition to a dye-only control, each virus was heated to 95°C prior to addition of 
SYBR gold to determine whether any reversible fluorescence changes originated from melting of DNA 
secondary structures. Data were normalized to baseline spectra obtained prior to and after complete 
thermal transition to obtain the ratio of uncoated particles to intact particles. Melting temperature (Tm) 
values were defined as the temperature at which uncoated and intact viral particles were at 50% each 
(uncoated particle ratio = 0.5). For subjecting samples to increasing osmotic pressure, wild-type AAV in 
PBS (pH 7.2) was supplemented with 5%, 10%, 20%, or 30% polyethylene glycol (PEG) 8000 (Sigma). 
For pH studies, samples at pH 5 and pH 6 were prepared by dialyzing wild-type AAV in citrate buffer 
(pH 5 or pH 6) supplemented with 137 mM NaCl. Samples at pH 7.2 were maintained in PBS. Error bars 
represent the standard deviation (n = 3). All AAV vectors were obtained from the UNC Vector Core, and 
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the size/nature of packaged genomes (ssDNA or scDNA) was blinded to the authors during these 
experiments. 
 
Immunoblotting (dot blotting) of heat-treated AAV particles 
Using a thermocycler, AAV packaging different transgenes was subjected to heat treatment. 
Wild-type AAV, empty AAV capsids, and AAV packaging single-stranded and self-complementary 
CMV-GFP genomes were heated to temperatures ranging from 40 to 73°C for 30 min prior to rapid 
cooling to 4°C (5 × 109 vg in 200 μl per well). Each virus was heated in duplicate and applied to two 
separate dot blots. Samples were loaded onto two nitrocellulose membranes in a dot blot apparatus. 
Membranes were blocked using 5% dehydrated milk in 1× Tris-buffered saline (TBS)–0.1% Tween 20 
(TBS-T) for 1 h. The monoclonal mouse antibody A20 recognizes a conformational epitope on the intact 
capsid, while the monoclonal mouse antibody A1 recognizes a linear epitope in the N terminus of the VP1 
capsid protein30. Membranes were soaked with primary antibodies (1:30 in 2% dehydrated milk in TBS-
T) for 1 h. Horseradish peroxidase (HRP)-conjugated goat anti-mouse polyclonal antibody (1:5,000) was 
then bound to the primary antibody for 1 h, followed by 4 washes using TBS-T and detection of signal 
using the West Femto chemiluminescence detection kit (ThermoFisher Scientific). 
Tungsten-shadowing electron microscopy.  
AAV vectors packaging ssDNA and scDNA cassettes containing cytomegalovirus (CMV) 
promoter-driven green fluorescent protein (GFP) (3 × 109 vg) were diluted in 10 mM Tris-HCl (pH 7.5) to 
1 × 1012 vg/ml. Dilutions were heated to 65°C for 5 min and then rapidly cooled on ice. Ten-microliter 
aliquots of these dilutions were then further diluted 1:3 in 10 mM Tris-HCl (pH 7.5), followed by 1:1 
dilution with a buffer containing 4 mM spermidine, and mounted to charged-carbon-foil grids as 
published previously31,32. Carbon grids were washed in water, dehydrated in a series of ethanol washes, 
air dried, and rotary shadow cast with tungsten. Samples were visualized on a Tecnai 12 transmission 
electron microscope at 40 kV. All microscopy images were captured using a Gatan Ultrascan 4000 
charge-coupled device (CCD) camera and supporting software (Gatan Inc.). 
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DNA and capsid modeling 
Following the report by Locker and Harvey33, the AAV genome was coarsely modeled by an 
elastic bead-spring polymer chain model, where each bead represented six nucleotide pairs. The 
molecular mechanics potential function used in this model was of the form  
(1) 
The stretching (Eri) and (Eθi) bending terms were modeled as harmonic oscillators of the form  
(2) 
where the equilibrium bond distances (α = r, ri being the distance between monomers i and i + 1) and 
angles (α = θ, θi being the angle between monomers i, i + 1, and i + 2) and their spring constants were 
chosen to match the structure and properties of ssDNA and double-stranded DNA (dsDNA) under 
physiological conditions. Specifically, as described previously33, we used statistical distributions of bond 
lengths in experimentally observed structures of DNA to derive stretching parameters of kr = 3.49 
kcal/mol/Å2 and r0 = 20 Å. Parameters for the bending term were chosen to match the persistence lengths 
and elastic properties of dsDNA and ssDNA observed experimentally, yielding values of θ0 = 180°, kθ = 
14.6 kcal/mol/rad2 for stiff chains representing double-stranded DNA, and kθ = 0.75 kcal/mol/rad2 for 
flexible chains representing single-stranded DNA. The exclusion term (Edij) gives the chain volume and 
prevents self-crossing using a shifted, repulsive-only Lennard-Jones function (equation 3):  
(3) 
where dij is the distance between monomers i and j, ε = 15 kcal/mol, σ = 22.27 Å, and d0, the effective 
chain diameter, was chosen to be 25 Å, consistent with observed values of interaction distances in packed 
dsDNA viral genomes34. No torsional restraints were included in the force field, and electrostatic and 
other long-range nonbonded interactions were also excluded in this simplified model. Chains of 350 
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monomers (representing 2,100 bp) were generated through a Monte Carlo random walk, with initial 
angles assigned from a Boltzmann distribution using the bending energy function for flexible chains 
given above and torsion angles randomly chosen from a uniform distribution. In this model, the 
icosahedral capsid was represented by a smooth sphere with a diameter of 216 Å (Rc = 108 Å), chosen to 
match the internal volume of the actual virus based on inspection of the X-ray crystal structure of the 
AAV-2 capsid (Protein Data Bank [PDB] no. 1LP3)35. The capsid restraint term was modeled as in 
equation 4 as a purely repulsive semiharmonic potential:  
(4) 
where Ri is the distance of monomer i from the center of the capsid and kc = 8.8 kcal/mol/Å2. 
 
MD simulations 
Molecular dynamics (MD) simulations were used to predict the organization and energies of 
encapsidated single-stranded and self-cDNA inside the AAV capsid. All simulations were carried out 
using the LAMMPS MD simulation package36 with a time step of 500 fs and at a temperature of 300 K 
maintained by a Nosé-Hoover thermostat37. 
Models of virus particles encapsidating ssDNA genomes were created by placing randomly 
generated flexible chains representing ssDNA inside spherical semiharmonic potential boundaries of the 
form given in equation 4 and gradually reducing the confining radius, Rc, from an initial value of 2,000 Å 
to 254 Å in 1-Å decrements, equilibrating the DNA chain for 5 ns at each step. At a bounding radius of 
254 Å, the DNA chain occupied 5% of the volume of the confining sphere, and it was allowed at this 
point to equilibrate over 50 ns of MD. The confining sphere was then shrunk further in 1-Å steps, 
following the same protocol of equilibrating for 5 ns after each 1-Å decrement and subsequently stopping 
to equilibrate for 50 ns at steps where the volume fraction of the DNA chain was a multiple of 5%. This 
was continued until the target Rc of 108 Å (containing 65% DNA by volume fraction) was reached. 
45 
 
Following confinement, the encapsidated ssDNA chains were converted step by step into dsDNA 
chains in order to simulate in situ base pairing of two adjacent ssDNA chains nucleated at the central ITR, 
as might occur in a self-complementary AAV vector. To accomplish this, the small spring constants of the 
bending terms in the flexible ssDNA chains (kθ = 0.75 kcal/mol/rad2) were converted, one angle at a time, 
to the larger value (kθ = 14.6 kcal/mol/rad2) characteristic of the stiffer dsDNA chains. The chains were 
allowed to equilibrate for 50 ns after each angle was stiffened, and the pressure (defined as the average 
total force exerted by the genome on the capsid walls divided by the surface area of the capsid) was 
calculated at intervals of 10% DNA base paired. Capsid pressure data were collected by using the radial 
positions of the monomers at each time step during the final 10 ns of the MD run to compute the average 
force exerted by the capsid restraining term (equation 4) and dividing by the surface area of the spherical 
capsid. 
 
Psoralen/UV-A (PUVA) Crosslinking: 
scAAV preparations were supplemented with 4'-aminomethyltrioxysalen  to a final concentration 
of 0, 25, or 250μg/ml and incubated at 37 °C for  30 minutes then irradiated with  a long-wave ultraviolet 
light at a distance of 7.6c m for 15minutes. 
 
Incubation/SSB Binding: 
scAAV samples were diluted to a concentration 3.3x1011vg/ml  with an estimated DNA 
concentration of 5 ng/ul in 10 mM Tris-HCl (pH 7.5) and 0.1 mM EDTA (EMTE) and incubated at 90 °C 
for 20minutes in the presence or absence of 50ng/ul of a recombinant extremely thermostable single 
stranded binding protein (ET SSB, New England Biolabs) then gradually cooled to 0 °C. ETSSB was then 
added to an scAAV samples that had not been incubated with ET SSB. All reactions were fixed via 
incubation with 0.6% glutaraldehyde for 5 minutes at room temperature. The reactions were then passed 
through a CENTRI•SPIN 40 (Princeton Separations) size exclusion column equilibrated with EMTE 
using a modification of the manufacturer’s protocol.  
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RESULTS 
Thermally induced DNA release is dependent on genome length 
AAV vectors have been previously shown to undergo structural transitions in response to limited 
heating20-22. We adapted this approach to determine the impact of thermal stimuli on encapsidated DNA. 
Atomic force microscopy (AFM) images of scAAV vectors heated to 65°C demonstrated release of AAV 
genomes from intact capsids (Fig. 3.1A), similar to the case for other parvoviruses such as MVM18. 
Further, we utilized transmission electron microscopy (TEM) to investigate whether the heated capsids 
contained DNA (full) or not (empty). Capsids which are intact and contain an encapsidated genome 
appear as 25-nm opaque/white spheres (Fig. 3.1B, panel i). In contrast, capsids which have released their 
packaged DNA are permeable to uranyl acetate and therefore appear as 25-nm rings (Fig. 3.1B, panels ii 
to v). In addition, as shown in Fig. 3.1B (panels vi to x), several capsid fragments and other morphologies 
were observed upon heating. 
Both ssDNA- and scDNA-packaging AAV capsids incubated at three different temperatures (37, 
55, and 65°C) were then visualized by TEM to quantify the populations of full and empty particles (Fig. 
3.2). At 55°C and 65°C, we observed an increase in the number of empty particles compared to that at 
37°C. Three different ssAAV vectors with genomes ranging from 72% (3.4 kb) to 100% (4.7 kb) of the 
wild-type genome length were characterized (Fig. 3.2A). After counting the numbers of full and empty 
particles, we observed a trend wherein AAV capsid stability appears to increase as genome size is 
reduced (Fig. 3.3A). Notably, when heated to 55°C, wild-type AAV (4.7 kb) has only 40% intact capsids 
remaining, while the 3.4-kb ssAAV vector is unaffected, with nearly 100% intact capsids. Similarly, at 
65°C, the wild-type AAV sample has ∼16% intact capsids remaining, while the shorter, 3.4-kb ssAAV 
vector still has 75% intact capsids. This trend is also seen in case of scAAV vectors, where the smallest of 
the three tested genomes (4.1 kb) has 79% intact particles at 65°C, while the largest of the three (5.0 kb) 
has only 9% intact capsids remaining at 65°C (Fig. 3.2B and 3.3B). 
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Figure 3.1 Ultrastructural characterization of AAV capsid uncoating. (A) Atomic force microscopy 
images of scAAV (sc-CMV-GFP) vectors heated to 37°C and 65°C. Viral particles are observed as 25-nm 
spheres. After heating to 65°C, viral genomes are detected both associated with viral particles and as free 
DNA (arrowheads). (B) Observed morphologies of heat treated AAV. Genome-containing AAV particles 
are impermeable to uranyl acetate (i), while empty AAV particles that have released DNA exhibit a ring-
like architecture (ii). Genome release resulted in diverse morphologies characterized by small gaps in the 
capsid wall (iii to v) as well as capsid fragments forming multimeric aggregates (vi to x). The scale bar 
represents 20 nm.   
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Figure 3.2 Effect of packaged genome length on AAV capsid uncoating. ssAAV (A) and scAAV (B) 
vectors were heated to different temperatures for 30 min prior to TEM imaging. Full AAV virions are 
viewed as 25-nm solid spheres, and empty virions are 25-nm donut-like structures. Differences in the 
relative amount of empty particles are apparent for different vector genome lengths. Genome lengths 
shown represent single-stranded DNA lengths (e.g., sc CMV-GFP is 2 × 2,058 bases + 3 × ITRs = 4,551 
bases). Images are representative of 10 to 20 captured images. Scale bars are 50 nm. 
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Figure 3.3 Quantitative analysis of TEM images. Thermally induced uncoating efficiency was assessed 
for intact-genome-containing (full) AAV particles packaging ssDNA (A) and scDNA (B) genomes of 
different length. Vectors were heated to 37, 55, or 65°C and visualized with TEM. Averages are taken 
from 10 to 20 images with particle counts for each sample ranging from 395 to 5,317 total particles. In all 
cases the average and standard deviation at each temperature was determined using the percentage of full 
particles from each image. Smaller capsid fragments (<50% of the shell) were excluded from counting. 
Genome lengths shown represent single-stranded DNA lengths. All values at 55°C and 65°C were 
determined to be significantly different from those at 37°C (P < 0.001 by a two-tailed Student t test). 
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scAAV vectors packaging a similar number of nucleotides are more thermostable than ssAAV 
vectors 
To explore the phenomenon of AAV genome release further, we developed a more sensitive, 
fluorescence-based thermal melt assay. Briefly, while impermeable to large fluorophores in the native 
state, heated AAV capsids would release encapsidated DNA that is free to interact with SYBR gold. This 
dye is known to exhibit >1,000-fold enhancement in fluorescence upon binding ss/dsDNA, with an 
excitation maximum of ∼495 nm and emission maximum of ∼537 nm38. To ensure that genome release is 
not rate limiting, the virus is held at each temperature for 5 min prior to reading the fluorescent signal. No 
large differences in fluorescence were observed between 5-min and 30-min heating periods (data not 
shown). At a critical temperature, we observed a sharp change in the fluorescence emission spectrum of 
AAV capsids packaging full-length genomes (Fig. 3.4A). When fluorescence intensities at the emission 
maxima were plotted as a function of temperature, we observed a sigmoidal profile with a characteristic 
thermal transition temperature (Fig. 3.4B). To further explore the applicability of this fluorimetric assay, 
we carried out similar studies evaluating thermally induced AAV genome release as a function of pH and 
osmotic pressure. As seen in Fig. 3.4C and D, AAV capsids appear to resist thermally induced genome 
release at lower pH and high external osmotic pressure. Next, we explored the phenomenon that self-
complementary AAV (scAAV) vectors appeared to be more thermostable than ssAAV in earlier EM 
studies (Fig. 3.2). Representative plots of three different AAV vectors packaging ssDNA genomes of 
different lengths are shown in Fig. 3.5A. The transition temperature is defined as the temperature required 
for 50% of the AAV particles to release their preencapsidated genomes. As outlined above, since genome 
release is irreversible, this measurement can be used to obtain a pseudo-Tm (abbreviated as Tm) rather than 
a thermodynamically determined melting temperature. It is also important to note that although AAV 
virions are noted as full or empty in these low-resolution EM studies, it is possible that uncoated capsids 
and associated genomes exist in multiple states. Such a scenario is supported by previous studies 
demonstrating the existence of different packaged AAV genome states based on high-resolution cryo-EM 
studies39. 
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Figure 3.4 Fluorimetric detection of AAV genome release under different conditions. (A) In the 
presence of SYBR gold (25 μM), AAV capsids were heated from 37°C to 95°C. At the point of genome 
release, an increase in fluorescence is observed at 550 nm (excitation, 495 nm), arising from the 
interaction between SYBR gold and the AAV genome. (B) When plotted and normalized to pretransition 
and posttransition baselines, a relatively sharp transition is observed in fluorescence at the emission 
wavelength. (C and D) Encapsidation stability is increased with decreasing pH (C) as well as increasing 
osmotic pressure (D). All experiments were repeated in triplicate.   
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Figure 3.5 Fluorimetric analysis of AAV capsid uncoating as a function of genome length and self-
complementarity. (A) Viral vectors were heated in 2°C increments and held for 5 min at each 
temperature prior to acquiring fluorescent signal. Three representative curves for different vector genome 
lengths are shown. Each vector was heated in triplicate along with a premelted control, which did not 
show a sharp transition. Curves were normalized to pre- and posttransition baselines to yield the 
percentage of released genomes. (B) Comparison of ssAAV, scAAV, and oversized ssAAV vectors 
shows an inverse linear correlation of Tm with vector genome size. 
 
Thermal transitions for different ssAAV vectors acquired from the UNC vector core were then 
plotted as a function of genome length (Fig. 3.5B). A linear correlation is observed, where Tm is inversely 
proportional to genome length. These data correlate well with the TEM data shown above. A similar trend 
is seen with the panel of self-complementary AAV vectors (it should be noted that genome length is 
shown as total single-strand length in Fig. 3.5). We also evaluated the thermal profile of AAV vectors 
packaging oversized ss/scDNA genomes. As mentioned above, the packaging capacity of AAV vectors 
has been studied extensively. Although numerous reports have demonstrated successful transduction with 
vectors packaging oversized AAV genomes, the latter have been shown to be fragmented into 
subgenomic-length DNA12,14,15,17. Therefore, it is not surprising that ssAAV vectors packaging a 5.8-kb 
genome exhibit a Tm similar to that of vectors packaging a smaller genome (3.4 kb). Surprisingly, scAAV 
vectors appear to be more thermally stable than ssAAV vectors in general. In addition, the thermal 
stability of scAAV vectors appears to be less sensitive to vector genome length than that of ssAAV 
vectors, as determined by the lower slope in the linear correlation (Fig. 3.5B). 
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Heat-induced exposure of VP1 N termini is not dependent on genome size or self-complementarity.  
While the current studies are focused primarily on the effects of thermal stimuli on AAV genome 
release, heat-induced exposure of AAV VP1 N termini has been reported by several groups21,22. Using a 
thermocycler, wild-type AAV, empty AAV capsids, and AAV packaging single-stranded or self-
complementary CMV-GFP genomes were heated to temperatures ranging from 40 to 73°C. Samples were 
then subject to immunoblot analysis using the monoclonal mouse antibody A20, which recognizes a 
conformational epitope on the intact capsid, and the monoclonal mouse antibody A1, which recognizes a 
linear epitope in the N terminus of the VP1 capsid protein30. As observed in Fig. 3.6, A20 staining is 
abrogated upon heating to temperatures of >60°C, indicating breakdown of intact capsids. Further, robust 
staining is observed at 60°C or higher, consistent with earlier studies by other groups. Interestingly, no 
significant difference was observed between samples regardless of full or empty particles or ssDNA or 
scDNA genomes. These results suggest that internal capsid pressure exerted by packaged AAV genomes 
might not play a direct role in externalization of VP1 N termini. 
 
 
Figure 3.6 Exposure of the VP1 N termini is not dependent on genome length or self-
complementarity. AAV capsids (5 × 109 vg/well) containing either the wild type (wtAAV), single-
stranded CMV-GFP (ssAAV), self-complementary CMV-GFP (scAAV), or no genome at all were heated 
in a PCR mixture for 30 min. The monoclonal antibodies A20 and A1 were then used to probe the AAV 
capsid integrity as well as the state of exposure of the buried VP1 N-terminal domain required for 
infection. No significant difference was observed between genomes with different sizes or self-
complementarity. 
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Tungsten-shadowing EM shows DNA secondary structure for dsDNA vectors 
The intriguing difference in the thermal properties of ssAAV and scAAV vectors suggests that 
the nature of secondary structures formed within encapsidated viral DNA might affect capsid uncoating. 
To investigate this phenomenon further, we visualized AAV DNA after DNA release using a combination 
of transmission electron microscopy and tungsten shadowing (Fig. 3.7). After heating the ssDNA-
packaging AAV vector to 65°C, the released viral genome was observed to collapse upon itself. This is 
likely due to kinetically driven base pairing within the ssDNA genome. In contrast, the scAAV genome 
clearly forms a dsDNA structure following release at 65°C. Furthermore, the mutated ITR located in the 
middle of the AAV genome is clearly observed. The thickness of the DNA in the images was consistent 
with the width of duplex DNA following coating with tungsten as measured in other studies31. Consistent 
with previous reports for other parvoviruses, the majority of viral DNA is observed associated with the 
capsid. These observations also suggest that a significant level of base pairing may exist in scAAV 
genomes prior to genome release. 
 
Molecular dynamics provides insight into genome organization within the capsid 
The persistence length of dsDNA is 50 nm (∼147 bp), which corresponds to a minimum dsDNA 
ring size of approximately 16 nm in diameter40. With a capsid shell that has an ∼22-nm inner diameter, 
one would expect that packaging 2.3-kb dsDNA into the AAV capsid would exert a large amount of 
internal pressure within the capsid shell41. It is therefore counterintuitive that scAAV vectors are more 
thermally stable than ssAAV vectors. Additionally, the observation of dsDNA in electron micrographs 
after heating suggests that cDNA base pairing could occur within the capsid. We therefore used molecular 
dynamics simulations to gather insight into the nature of the DNA within the capsid. 
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Figure 3.7 Tungsten-shadowing EM of released genomes from ssCMV-GFP (A and C) and scCMV-
GFP (B and D) vectors. Viral particles were heated to 65°C and then imaged using tungsten-shadowing 
EM. Grids showed a combination of AAV virions shown as spheres, loose DNA, and virion-associated 
DNA. Scale bars represent 50 nm. Insets are cartoon representations of the predicted secondary structure. 
 
In this model, the capsid is represented as a hollow sphere. Packaged DNA is represented as an 
elastic bead polymer chain of varying flexibility (high for ssDNA and low for dsDNA). Spheres 
containing ssDNA chains were reduced in diameter from 200 nm to 21.6 nm while performing molecular 
dynamics to sample conformational space and achieve thermal equilibrium before determining the capsid 
pressure, measured by the average total force exerted by the genome on the capsid walls divided by the 
surface area of the capsid. Encapsidated ssDNA chains were modified to have increasing degrees of 
double-stranded character by increasing the stiffness of the angle constraints between monomers, one at a 
time, simulating base pairing along an scAAV genome. 
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Counterintuitively, we find that as the angle stiffness is increased step by step along the confined 
chain, the pressure exerted by the chain on the capsid walls decreases until about 50% of the genome has 
been base paired, reaching a capsid pressure of 5.2 ± 0.1 atm (Fig. 3.8A). Further base pairing causes the 
capsid internal pressure to rise up to a maximum of 8.3 ± 0.7 atm. Visualizing the MD trajectory of the 
base pairing simulation provides insight into this phenomenon (Fig. 3.8B). Before base pairing begins, the 
ssDNA is largely disordered (blue licorice in Fig. 3.8B). The small bending energy penalty leaves the 
beads at the outer surface free to vibrate (due to thermal energy) against the capsid walls, creating 
pressure. As the chain is base paired by increasing the stiffness sequentially along the length of the chain, 
the stiffened segment attempts to reduce its bending energy by moving away from the capsid center, 
forming concentric rings near the surface of the containing sphere (red beads in Fig. 3.8B, panel ii). 
Unlike the flexible ssDNA chain, these dsDNA rings are not able to vibrate freely due to their increased 
stiffness, and thus they exert less pressure on the walls. As the degree of base pairing approaches 50%, 
the surface of the DNA sphere is almost completely covered by these stiff concentric rings, which stack to 
form a tight shell around the core of flexible ssDNA, damping their vibrations against the capsid walls 
(Fig. 3.8B, panel iii). As base pairing continues along the chain, a second inner layer of concentric rings 
begins to form, which pushes the outer layer further toward the capsid wall (Fig. 3.8B, panels iv and v). 
As the degree of base pairing increases, the force from this inner layer transmitted through the outer shell 
to the capsid increases, causing the capsid pressure to rise. 
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Figure 3.8 Computational modeling of internal capsid pressure and genome organization. (A) In 
molecular dynamics simulations, the stiffness of modeled ssDNA chains was increased step by step along 
the chain to simulate DNA base pairing in scAAV genomes. Pressure exerted on the capsid walls 
decreases until 50% of the chain has been converted, after which the capsid pressure increases. Error bars 
represent standard deviations (n = 5). Cartoon representations of predicted secondary structures of AAV 
genomes at different levels of base-pairing are shown above the curve. (B) Molecular dynamics 
simulation of progressive change in the organization of flexible ssDNA chains (cyan licorice) while being 
base paired into stiff dsDNA chains (red beads). Representative snapshots of chain organization within 
the model capsid at 0% (i), 25% (ii), 50% (iii), 75% (iv), and 100% (v) conversion of ssDNA to dsDNA 
are shown. dsDNA segments are seen to migrate to the periphery and adjacent to the inner capsid surface, 
where they may buffer the thermal motion of the flexible ssDNA chain and reduce the pressure exerted on 
the inner capsid walls during the initial stages of the conversion process. The development of an inner coil 
of dsDNA after 50% conversion may subsequently contribute to increasing capsid pressures. 
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We note that several simplifications have been made in constructing the model of the scAAV 
genome, most notably the omission of electrostatic interaction terms from the force field. Simulations of 
DNA packaging in bacteriophages in which electrostatics were included showed that DNA-DNA 
repulsions accounted for up to 51% of the total free energy cost of packaging, suggesting that these forces 
dominate when the genome is highly confined42. However, we also note that the genome conformations 
resulting from these simulations were topologically indistinguishable from those in similar systems where 
electrostatics was not accounted for43. The electrostatic interaction energy, although a significant 
component of the energetics of packaging, depends primarily on the total DNA density and is largely 
agnostic to conformational details, which are dictated by the elastic bending terms in the force field. Since 
DNA bending is accurately represented in our model, we believe that, even in the absence of 
electrostatics, our simplified model correctly predicts the qualitative topology of the scAAV genome and 
its influence on the measured capsid pressure.  
 
EM quantification of DNA release following thermal denaturation 
Quantification of the adherence of AAV capsid protein to the grids used for our EM 
characterization revealed that scAAV adhered at consistently higher abundance than ssAAV (Figure 
3.9A). This difference in capsid protein abudance may simply reflect the fact that AAV concentration was 
determined via a PCR based assay that quantified the presence of the viral genomic DNA. Regardless, the 
adherence of both scAAV and ssAAV was increased following mild thermal denaturation at 55 °C. 
However, denaturation at higher temperatures appeared to reduce capsid adherence. This may be due to 
disruption of the capsid structure, aggregation of the capsid proteins following denaturation or other 
unknown confounding factors. Thermal denaturation results in the release of viral genomes from both 
scAAV and ssAAV (Figure 3.9B). Denaturation at increasing temperatures results in the release of 
increasing amounts of both single- and double-stranded genomes, through the binding of single- stranded 
genomes did appear reduced when denatured at 65 °C versus 60°C. Following thermal denaturation a 
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large portion of the genomes released remained associated with capsid protein (Figure 3.9C), approaching 
100% at the highest tested denaturation temperature.  
 
 
 
Figure 3.9: Characteristics of capsid adherence and genome release following thermal 
denaturation. (A) ssAAV and scAAV capsids adhere to EM grids in comparable numbers, and this 
adherence is dependent upon denaturation temperature. (B) scAAV and ssAAV genomes are released 
from their capsids by thermal denaturation. (C) scAAV and ssAAV genomes remain capsid-bound 
following release from the capsid in comparable abundance.   
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A careful examination dsDNA genomes following thermal denaturation revealed that they 
adopted a discreet set of structured (Figure 3.10A-E). The ends were either AAV Bound (Figure 3.10A) 
or free (Figure 3.10A), or they possessed a secondary (2’) structure comparable to that expected at the 
inverted terminal repeats (Figure 3.10C), or a looped structure (Figure 3.10D) or a looped structure with a 
dsDNA tail (Figure 3.10E). Of genomes possessing two classifiable ends, the plurality of ends were of a 
free conformation, regardless of thermal denaturation, with a substantial minority of ends possessing the 
2’ structure  (Figure 3.10F). Following denaturation increasing numbers of ends were observed to be 
AAV bound, with his minority overtaking the ends possessing the 2’ structure. The proportion of 
genomes possessing particular end-structure combinations was affected by temperature. Prior to 
denaturation the plurality of genomes possessed a free end and an end with the expected 2’ structure, with 
a sizable minority possessing two free ends (Figure 3.10G). Following thermal denaturation there was a 
profound increase in the abundance of AAV bound genomes possessing a free, and a concomitant slight 
increase in AAV bound genomes possessing an end with the expected 2’ structure and a decrease in the 
abundance of other species. Analysis of the length of these genomes did not reveal any clear trends, 
whether when classified by end structure (Figure 3.10H) or end-structure combination (Figure 3.10I). 
However, these length-analysis data were possessed of considerable variability (not shown), which 
hinders meaningful comparisons.  
 
Attempts at characterizing intra-capsid structure by EM 
Incubating a solution of scAAV particles for 20 minutes at 90 °C then gradually cooling it to 0 °C 
produces a solution of proteins and annealed scAAV genomes that are amenable for examination using 
transmission electron microscopy (TEM). 4'-aminomethyltrioxysalen (psoralen) is an intercalating agent 
that can form a thymidine diaduct at TA sequences in double-stranded DNA upon exposure to long-wave  
ultraviolet light (UV-A), forming a stable interstrand crosslink. Treatment of intact scAAV particles with 
psoralen and UVA (PUVA) is expected to extensively crosslink the scAAV genome only if the genome is 
double stranded inside the capsid.  Extremely-thermostable single stranded DNA binding protein (ET 
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SSB) is able to stably bind to single-stranded DNA at temperatures of up to 100°C, but has low affinity 
for double-stranded DNA. ET SSB is expected to fully coat the scAAV genome following PUVA 
treatment only if the genome is not extensively crosslinked. Faux-PUVA treated (0 μg/ml Psoralen) 
scAAV genomes appear as double-stranded DNA when incubated in the absence of ET SSB (Figure 
3.11A) and ET SSB coated filaments when incubated with ET SSB (Figure 3.11B). scAAV genomes 
PUVA treated with either 25 μg/ml (Figure 3.11C) or 250 μg/ml (Figure 3.11D) psoralen show no 
appreciable difference from the Faux-PUVA treated scAAV genomes.  
 
 
 
Figure 3.10: EM analysis of end structure and genome length. Genome end structures consist of AAV 
bound ends (A), free ends (B), ends with 2’ structure  consistent with an ITR (C), a loop structure (D) or a 
loop structure with a dsDNA fail (E). The relative abundance of these ends structures changes following 
thermal denaturation (F), and the relative abundance of genomes possessing particular combinations of 
these end structures also changes following thermal denaturation (G). The length of genomes possessing 
these end structures (H) or particular combinations of end structures (I) do not show clear differences 
following thermal denaturation.  
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The lack of extensive crosslinking after PUVA treatment may be due to a number of factors. The 
scAAV genome may be packaged as single-stranded DNA (ssDNA) in the capsid, the capsid may be 
impermeable to psoralen, or the PUVA treatment may have failed for technical reasons. That scAAV may 
be packaged as ssDNA is plausible; natural AAV genomes are single-stranded2. However, psoralen 
potentiates UV inactivation of AAV, perhaps suggesting both that the genome is capable of limited base 
pairing in the capsid and that capsid is permeable to psoralen5. Future studies may test the success of 
PUVA treatment by crosslinking a sample of heat-denatured and annealed scAAV as a positive control. 
Ultimately the results of this preliminary examination do not contradict the model that scAAV genomes 
are packaged into AAV capsids as ssDNA, but its design lacks a control needed to generate results that 
could actually support that model. 
 
DISCUSSION 
Parvoviruses such as minute virus of mice (MVM) have been shown to release their ssDNA 
genomes in the 3′-to-5′ direction, while leaving the empty virus shell intact18. Our studies indicate that 
AAV capsids respond in a similar manner to thermal stimuli. We observed different capsid fragments and 
morphologies that suggest that empty AAV shells might subsequently unravel from the site of genome 
release, presumably by loss of the viral proteins comprising the virion shell. Such capsid disassembly 
intermediates are not observed upon heating purified empty AAV particles (data not shown), which 
suggests that capsid disassembly might not precede genome release. Interestingly, heat-induced exposure 
of AAV VP1 N termini has also been reported by several groups21,22. In the current study, both VP1 
exposure and genome release were observed to occur upon heating capsids to approximately 60°C or 
higher (Fig. 3.4 and 6). Paradoxically, we observed that heat-induced exposure of VP1 N termini does not 
vary significantly between wild-type AAV, empty AAV virion shells, and representative ssAAV or 
scAAV vectors (Fig. 3.6). Based on these results, one possible scenario is that parvoviral VP1 exposure 
and genome release might be structurally distinct events with a certain degree of temporal overlap, as 
proposed earlier18. It is important to note that despite our experiments providing insight into biophysical 
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aspects of AAV capsid uncoating, their biological implications remain to be established. Nevertheless, the 
results underscore the importance of understanding capsid structural transitions that precede VP1 
exposure and genome release as well as spatiotemporal aspects of such events in the AAV infectious 
pathway. 
 
 
 
Figure 3.11: Psoralen fails to crosslinks scAAV genomes in intact capsids. (A) an scAAV genome. 
(B) an scAAV genome incubated in the presence of ET SSB shows ET SSB binding. Psoralen 
crosslinking with 25 μg/ml (C) or 250 μg/ml psoralen (D) do not affect ET SSB binding to the scAAV 
genome. 
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Using a combination of electron microscopy and fluorimetric assays, we observed a trend 
wherein subgenomic AAV particles require more thermal energy to release their genomes, regardless of 
whether they are packaging ssDNA or scDNA. In contrast as genome sizes approach wild-type AAV 
genome length (∼4.7 kb), the capsids appear to acquire an optimal, metastable stable state that can 
efficiently uncoat. Packaged DNA genomes within bacteriophages can generate pressures of close to 50 
atm41,44,45, requiring only minimal stimuli for DNA ejection, but these pressures rapidly drop off as the 
length of phage DNA is decreased to 78% of wild type41. One might therefore expect that AAV vector 
genomes of different subgenomic size would greatly change the internal pressure of the capsid. Thus, it is 
likely that subgenomic AAV particles are defective in capsid uncoating and genome release within the 
host cell. Accordingly, incorporation of stuffer DNA and packaging of near-wild-type genomes into AAV 
capsids might improve infectivity. Further, we also observed that acidic pH and external osmotic 
pressures exerted by ∼30% PEG 8000 solutions inhibited AAV capsid genome release. One possible 
explanation for the stabilizing effect of low pH on AAV capsids might be increased interactions between 
packaged DNA and positively charged histidine side chains within the capsid interior. Additionally, we 
surmise that the observed increase in capsid stability and genome retention at acidic pH may be beneficial 
from a physiological standpoint. Enhanced capsid stability within endosomal/lysosomal compartments 
during intracellular trafficking could help protect viral DNA from degradation by nucleases prior to 
release into the nucleus. The osmotic pressure effect is corroborated by earlier studies with bacteriophage 
capsids, wherein genome ejection was observed to be inhibited by pressures comparable to that of the 
cytoplasm of bacteria46. Another interesting observation was that AAV vectors packaging genomes larger 
than wild type exhibit stability equivalent to that of subgenomic particles. This result can be explained by 
earlier studies demonstrating that packaged genomes for oversized AAV vectors are truncated12,14,15,17. 
Lastly, the observation that scAAV vectors are more thermally stable than ssAAV vectors was 
unexpected. Since dsDNA is inherently stiffer than ssDNA, one would expect packaging a fully base-
paired dsDNA genome into an AAV capsid to be energetically unfavorable. Our results from molecular 
modeling studies support the notion that internal pressures associated with capsids packaging dsDNA 
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genomes could indeed be higher than those associated with ssDNA-packaging vectors. However, closer 
analysis of the modeling data revealed that a hybrid AAV genome comprised of ssDNA and dsDNA 
(50% base pairing) would exert an internal capsid pressure that is lower than that with 100% ssDNA 
alone. These theoretical predictions are supported indirectly by tungsten-shadowing EM studies, wherein 
we observed predominantly dsDNA character in released scAAV genomes. In contrast, the ssAAV 
genome was observed to form a disordered structure consistent with folding of DNA into a local 
thermodynamic minimum. Therefore, it is tempting to speculate that partially base-paired scAAV 
genomes might nucleate rapid annealing upon release to form a complete dsDNA structure in the host 
cell. Although these results suggest that scAAV vectors might be more resistant to uncoating than ssAAV 
vectors, this apparent defect is likely offset by bypassing second-strand synthesis, which results in rapid 
onset of transgene expression. In summary, these studies provide a path forward toward characterization 
of AAV capsid uncoating and genome release in a more relevant physiological setting. When integrated 
with intracellular trafficking studies and high-resolution structural data, it is possible that the results 
described here might provide a more complete picture of AAV infection and possibly guide the design of 
optimal AAV vector genomes for gene therapy applications. 
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Chapter 4: A Guanosine-Centric Mechanism for RNA Chaperone Function1 
 
Introduction 
Outside the cellular environment or in the absence of chaperone proteins, most RNAs fold via 
complex pathways involving multiple, long-lived intermediates. RNA chaperone proteins with non- or 
semispecific RNA binding activities accelerate adoption of the thermodynamically most stable RNA 
structure by lowering the energetic barriers between RNA states and by facilitating rearrangement of 
misfolded states1–4. Retroviruses package two RNA genomes in each virus particle5. These genomes 
dimerize near their 5′ ends, and dimerization is catalyzed by an RNA chaperone, nucleocapsid (NC), 
which is derived from the retroviral Gag protein that coassembles with the viral RNA to generate 
replication-competent virus2,6,7. By following the dimerization of a region of the Moloney murine 
leukemia virus (MuLV) genomic RNA at single-nucleotide resolution, we uncovered a simple mechanism 
for how a retroviral nucleocapsid chaperone protein functions.  
 
MATERIALS AND METHODS 
Retroviral RNA transcripts 
The MuLV RNA fragment analyzed here is 331 nts and spans the dimerization and packaging regulatory 
domain (~170 nts). The RNA includes 5' and 3' flanking sequences of 46 and 115 nucleotides that 
facilitate primer extension analysis of SHAPE adducts. This RNA has a structure similar to the same 
region in authentic genomic RNA isolated from virions11,12. The transcript was synthesized and purified 
________________________ 
1 The following chapter describes work done in collaboration with Dr. Jacob Grohman, Mr. Colin 
Lickwar, Dr. Jason Lieb, Dr. Brent Znosko and Dr. Kevin Weeks. I significantly contributed the 
purification of the hnRNP A1 used in the experiments reported below33.  
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as described12. For the inosine-substituted RNA, transcription was performed in the presence of inosine  
triphosphate instead of guanosine triphosphate. 
 
NC and UP1 proteins 
The MuLV retroviral nucleocapsid protein was purified as described24. The UP1 open reading 
frame was amplified by PCR from a vector containing the hnRNP A1 cDNA (GenBank NM002136) and 
cloned into the Bam HI and Not I sites of pET28a (Invitrogen) to yield an Nterminal (His)6-tagged 
version. UP1 was expressed in BL21(DE3)pLysS E. coli cells (Invitrogen) in 2 L LB using standard 
approaches. Cells were recovered by centrifugation and resuspended in 100 ml of 10 mM Tris-HCl (pH 
7.4), 5 mM β-mercaptoethanol, 200 mM NaCl (supplemented with EDTA-free protease inhibitors; 
Roche) and lysed by incubation with 1 mg/ml egg-white lysozyme (20 min at 4 °C) and 5 min of 
sonication (Branson Sonifier 450, 75% duty cycle, tip setting of 6, at 0 °C). This lysate was separated via 
centrifugation (Beckman SW28 rotor at 131,000 ×g, 1 hr at 4 °C), and the (His)6-UP1 protein was 
affinity purified using 1.0 ml Ni-NTA agarose beads (Qiagen; equilibrated in resuspension buffer 
overnight at 4 °C). Following three 50 ml washes [in 10 mM Tris-HCl (pH 7.4), 500 mM NaCl, 5 mM β-
mercaptoethanol, 5% (v/v) glycerol, 25 mM imidazole], UP1 was eluted from the beads with 10 ml of 10 
mM Tris-HCl, 150 mM NaCl, 250 mM imidazole (pH 7.5). The eluate was dialyzed against 4 L 20 mM 
HEPES (pH 7.4), 0.2 mM EDTA, 10% (v/v) glycerol, 1 mM DTT, 0.1 M KCl overnight at 4 °C using a 
10-kDa cutoff dialysis cassette (Thermo Scientific). The protein was quantified by measurement of 280 
nm absorbance; aliquoted; flash frozen in liquid nitrogen; and stored at -80°C until use.  
 
Time-resolved SHAPE 
MuLV domain RNAs (120 and 40 pmol for the 600 nM and 200 nM reactions, respectively) were 
renatured in RNase-free water by heating at 95 °C for 3 min in a total volume of 150 μL and cooled on ice 
for 3 min. The resulting monomers were then equilibrated at 37 °C for 3 min by adding 40 μL of a 5× 
folding buffer, omitting magnesium ion [50 mM HEPES (pH 7.5), 200 mM potassium acetate (pH 7.5)]. 
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A pre-reaction (0 sec) time point was taken before magnesium ion addition to capture the initial monomer 
state. Time-resolved SHAPE experiments were then initiated by the addition of MgCl2 to 5 mM (using 10 
μL at 100 mM) at 37 °C, and the RNA structure was interrogated over a time course spanning 7 sec to 1 
hr. For each time point, SHAPE modification was performed by adding 9 μL (5.4 and 1.8 pmol for the 
600 and 200 nM reactions respectively) of the evolving MuLV RNA reaction to 1 μL BzCN (200 mM in 
DMSO) at 25 °C; immediate vigorous pipetting ensured mixing. Reaction with BzCN is complete within 
~1 sec (13). No-reaction controls used neat DMSO. RNA was recovered by ethanol precipitation [2.5 vol 
ethanol, 1 μL glycogen (20 mg/mL), incubation at -20 °C for 60 min, and centrifugation at 20,000 ×g]. 
Pellets were resuspended in 6 μL 1/2× TE [5 mM Tris, 0.5 mM EDTA (pH 8.0)] buffer. The dimerization 
reactions in the presence of a saturating amount of NC or UP1 protein (80 μM in 1 μL) were performed 
identically except the total initial volume of RNA in water was 149 μL and the proteins were added as a 
mixture with magnesium (11 μL total volume). For reactions containing NC or UP1, after SHAPE 
modification, bound protein was removed by digestion with proteinase K [60 μg (Invitrogen); 10 min, 37 
°C] followed by extraction with phenol:chloroform:isoamyl alcohol (25:24:1) prior to ethanol 
precipitation.  
 
Optimal concentration of NC to facilitate dimerization 
The equilibrium dissociation constant for NC binding to short sequences containing guanosine is 
100-400 nM17, and thus most of the NC protein is likely bound under the conditions used in our 
experiments. We determined the concentration of NC that yielded the largest acceleration of the MuLV 
dimerization reaction empirically. Observed dimerization rates increased as the NC concentration was 
increased from 2 to 8 μM and did not increase further as the concentration was increased to 16 μM. An 8 
μM NC concentration was therefore chosen as the standard condition for these experiments.  
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Primer extension and data processing 
MuLV primers (5'-GGUGC ACCAA AGAGU CCAAA AGC-3', LNA nucleotides are 
underlined, 5'-end labeled with 5-FAM or 6-JOE) were complementary to the 3' end of the MuLV 
dimerization domain (nucleotides 422 to 445)25. Primers (1 μL; 10 pmol) were annealed to MuLV domain 
RNA (6 μL; 5.4 pmol in 1/2× TE buffer) by heating at 65 °C and 45 °C for 5 min each and then were 
snap-cooled on ice. Reverse transcription buffer [3 μl; 200 mM Tris (pH 8.0), 250 mM KCl, 10 mM 
MgCl2, 2 mM each dNTP, 20 mM DTT] was added at 0 °C, and primer extension was performed with 
Superscript III (Invitrogen) reverse transcriptase (0.5 μl; 100 U) at 45 °C for 1 min, followed by 
incubation at 52 °C and 65 °C for 10 min each. Reactions were quenched by addition of 3 M sodium 
acetate (pH 5.2) and cooling to 4 °C. A sequencing marker was generated by adding 0.5 μL ddGTP (10 
mM) to the primer extension reaction mixture using unmodified RNA. The BzCN and DMSO reaction 
mixes were each combined with equal amounts of ddGTP-terminated sequencing ladders, precipitated 
with ethanol, and resuspended in deionized formamide (10 μL). cDNA fragments were resolved on an 
Applied Biosystems 3130 capillary electrophoresis (CE) instrument. Time-resolved SHAPE data were 
processed using QuShape26 (available at chem.unc.edu/rna/qushape). The initial raw sequence trace was 
corrected for dye variation and signal decay. Peak intensities were scaled, aligned, integrated, and 
normalized using a suite of optimized statistical algorithms. After analysis of the reference trace, 
subsequent time points were automatically analyzed by alignment to the saved project file as a reference 
trace26. Each CE separation contained a reaction performed in the presence or absence of BzCN (labeled 
with 5-FAM) and a sequencing reaction (labeled with 6-JOE) performed using ddGTP. 
 
RNA structure modeling 
To develop secondary structure models for intermediate states, SHAPE reactivity information 
was used to impose a pseudo-free energy change constraint in conjunction with nearest neighbor 
thermodynamic parameters in the secondary structure modeling program RNAstructure19,27. To develop 
approximate secondary structure models for the inosine substituted RNA (Fig. S3), we replaced 
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guanosine nearest-neighbor parameters with their corresponding inosine parameters in a modified version 
of RNAstructure; loop and bulge parameters used the existing values for guanosine. A-U, G-C, G-U, and 
I-U nearest neighbor parameters were reported previously18,22,28. I-C nearest neighbor parameters were 
calculated as described18. Average nearest neighbor free energy change contributions (ΔG°37) and 
standard deviations (Fig. 4A) were calculated from all possible nearest neighbor combinations containing 
the base pair of interest (G-C, I-C, or A-U) adjacent to a Watson-Crick pair. 
 
k-means clustering 
SHAPE profiles were sorted by individual nucleotide kinetic behaviors by k-means clustering 
using Cluster 3.016. We employed the following kinetics-specific features: (i) under the kmeans option, 
we organized the kinetic data for each nucleotide by rows (termed "genes" in Cluster); (ii) under the 
Adjust Data option, we used Normalize Genes; and (iii) we used the absolute correlation (uncentered) 
similarity metric to organize each row (or nucleotide-specific kinetic dataset). Clusters were visualized 
using TreeView16 [M. Eisen, Cluster and TreeView online manual (1998)]. To determine the optimal 
number of clusters, k-means clustering was initially performed starting from k = 2 through 10 (9 trials 
total). For each k value, clustering was reiterated both 100 and 1000 times, the optimal solutions were 
found twice, and the clustering solution with the smallest sum of within-cluster distances was accepted. 
The optimal cluster number for each experiment was chosen independently of the initial k value. For 
example, for the RNA-alone reactions, seven clusters were apparent in the optimal solution, which 
occurred at k = 7. Seven was also the optimal number of clusters when higher k values (including k = 8, 9, 
and 10) were initially input. Forced division of the data by k values >7 resulted in overcategorizing 
nucleotides with slightly varying reactivities (net reactivity changes of less than 0.2 SHAPE units) as 
having a distinctive kinetic behavior. For the NC, UP1 facilitated, and inosine variant RNAs, the same 
procedure for finding the optimal number of clusters consistently yielded an optimal solution at k = 3. 
Further increasing the k value in the initial search did not result in formation of any apparent new clusters. 
For most clusters, observed rates for individual nucleotides were the same, within error. In the case of 
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cluster 1, the kinetic profiles were characterized by two fast rates; this cluster was divided into two 
groups, 1a and 1b. For each grouping, net rates are reported as the mean ± standard deviation over all 
nucleotides in the cluster.  
 
Dimerization followed by non-denaturing electrophoretic mobility shift 
The native MuLV domain RNA, internally labeled with 32P (~0.5 nM), was mixed with 
unlabeled RNA (600 nM in 15 μL of water). Reactions were treated exactly as per the time-resolved 
SHAPE experiments, outlined above. Briefly, samples were heated to 95 °C to denature, rapidly cooled 
on ice, and equilibrated with 5 μL of a 5× folding buffer without magnesium ion [50 mM HEPES (pH 
7.5), 200 mM potassium acetate (pH 7.5), at 37 °C]. The reaction was initiated by the addition of MgCl2 
to 5 mM (5 μL, 25 mM) at 37 °C, for a final volume of 25 μL. Time point aliquots (3 μL) were mixed 
with 5 μL of 30% (v/v) glycerol (containing marker dyes), loaded directly onto a running non-denaturing 
gel (5% polyacrylamide; 29:1 acrylamide/bisacrylamide, in TBE; 0.4 mm × 28.5 cm × 23 cm gel), and 
resolved by electrophoresis at 4 °C for 2 h at 20 W. Observed rates are reported as the mean ± standard 
deviation from three independent experiments. 
 
RESULTS AND DISCUSSION 
We studied an RNA construct spanning the 170-nucleotide (nt) MuLV dimerization region8–10 
and including 5′ and 3′ flanking sequences of 46 and 115 nucleotides, respectively. This RNA dimerizes 
under physiological-like conditions in vitro and has a structure similar to that of genomic RNA isolated 
from virions11,12. Point mutations in this region of the MuLV genome eliminate its selective packaging 
into virions10. We followed dimerization at single-nucleotide resolution using time-resolved, selective 2'-
hydroxyl acylation analyzed by primer extension (SHAPE)13,14. A fast-acting reagent, benzoyl cyanide 
(BzCN), that either reacts to form a 2'-O-adduct at conformationally flexible nucleotides or undergoes 
rapid self-inactivation by hydrolysis (with a 0.25-s half-life), was used14. Each time point, obtained over 
reactions spanning tens of minutes, thus yields a structural snapshot of ~1 s duration.  
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SHAPE profiles for the initial monomer and final dimer forms agree well with accepted structures for the 
MuLV dimerization domain (Fig. 4.S1 and text 4.S1). Five key regions underwent large-scale structural 
changes during dimerization (Fig. 4.1). The loops of hairpins SL1 and SL2 (positions 329 to 332 and 363 
to 366, respectively) were reactive in the monomer and became unreactive during dimerization (within 7 
s), consistent with formation of a stable intermolecular loop-loop kissing interaction15. Two palindromic 
sequences, PAL1 (positions 210 to 219) and PAL2 (positions 283 to 298), were initially reactive but 
became unreactive because of intermolecular duplex formation in the dimer. Conversely, two regions that 
form the “anchoring helix” (positions 231 to 251 and 290 to 315) in the monomer became more reactive 
upon dimer formation (Fig. 4.1 and fig. 4.S1).  
 
 
 
Figure 4.S1: Secondary structures of monomer and dimer states. Nucleotides are colored by SHAPE 
reactivity. RNA motifs that undergo the largest structural changes during dimerization are labeled. For 
clarity, only one strand of the dimer is colored. 
 
Text 4.S1: SHAPE profiles for the initial monomer and final dimer forms agree well with accepted 
structures for the MuLV dimerization domain, including those obtained using authentic genomic 
RNA10,12,25 (Fig. 4.S1). Nucleotides with high SHAPE reactivities are conformationally dynamic29,30 and 
generally occur in single-stranded regions of the RNA secondary structure (Fig. 4.S1, red nucleotides). 
Conversely, nucleotides with low SHAPE reactivities (Fig. 4.S1, black) tend to be base paired. Each time 
point is effectively a structural snapshot of ~1 second duration. These 1-second snapshots are sufficient to 
monitor many features of RNA dynamics; however, there are also likely to be additional features of the 
reaction that occur more rapidly than measured here. 
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Fig. 4.1 Time-resolved SHAPE analysis of MuLV RNA dimerization. SHAPE reactivities are shown 
for monomer (no magnesium), dimer (60 min), and representative time points in which specific structural 
intermediates predominate. Key structural interactions that change during dimerization are highlighted 
within sets of dashed blue lines.   
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We obtained SHAPE data for every nucleotide within the 170-nt MuLV domain in 16 1-s 
snapshots yielding more than 2700 structural data points. We grouped nucleotides with similar kinetic 
behaviors by k-means clustering16. In the presence of 5 mM Mg2+ and without a protein chaperone, there 
were seven distinct kinetic behaviors involving four net rates (Fig. 4.2A). Rates were identical, within 
error, over a three-fold change in RNA concentration (fig. 4.S2), indicating that most conformational 
changes reflect pseudo-unimolecular transitions between two interacting RNAs. The fastest rate of ≥5 
min–1 (Fig. 4.2A; cluster 1a, in orange on structures at bottom) occurred at nucleotides at the apexes of 
SL1 and SL2, suggesting formation of a complex between two RNAs before the first time point. PAL1 
nucleotides became less reactive at a net rate of 1.6 ± 0.4 min–1 (Fig. 4.2A, cluster 1b, green on 
structures). The anchoring helix and PAL2 nucleotides demonstrated opposing kinetic behaviors (rates of 
0.30 ± 0.03 min–1) (Fig. 4.2A, clusters 2 and 3, in red), suggestive of a single process involving both 
structures. Positions in a large, flexible domain (positions 251 to 282) showed slower kinetic behavior 
with a net rate of 0.11 ± 0.02 min–1 (Fig. 4.2A, cluster 4, in black on structures). Finally, nucleotides in 
clusters 5 and 6 showed biphasic kinetic behavior in which the SHAPE reactivity first increased and then 
decreased over time, or vice versa, with rates of 1.6 and 0.1 min–1. Time-resolved SHAPE analysis of the 
MuLV domain thus reveals that dimerization is complex, slow, and characterized by multiple structurally 
distinct transitions and intermediates.  
We next performed an analogous set of experiments initiating dimerization by simultaneous 
addition of magnesium ion and the MuLV NC protein. With the addition of chaperone, clustering of the 
SHAPE data revealed that the NC protein collapsed dimerization into a single kinetic process that 
occurred at a net rate of 1.6 ± 0.4 min–1 (Fig. 4.2B). There was no evidence of the slow and multirate 
processes that characterized the RNA-only reaction. Initial binding interactions between the NC 
chaperone and RNA monomer were readily detected in a difference analysis in which the SHAPE profile, 
immediately after NC binding, was subtracted from that of the reactivity profile of the free RNA (Fig. 
4.3A). Of the 29 nucleotides with the largest changes in SHAPE reactivity, 19 (or 66%) are guanosine 
residues (Fig. 4.3, A and B, and text 4.S2), consistent with studies showing that NC contains a cleft that 
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binds guanosine17. Sites of protection (positive peaks) likely correspond to sites of stable binding by NC 
during the 1-s window of the time-resolved SHAPE experiment; the smaller number of guanosine 
residues with higher reactivity in the presence of NC (negative peaks) likely reflect either a rapid binding 
and release or NC-induced conformational changes.  
 
 
Fig. 4.2 Model-free clustering of nucleotide-resolution kinetic profiles for dimerization. SHAPE 
reactivities at 600 nM MuLV RNA (A) in the absence of and (B) in the presence of 8 μM NC, and (C) for 
an RNA containing inosine in place of guanosine. Each data point is shown on a scale (black to red) 
corresponding to its SHAPE reactivity (see Fig. 4.1). The y axis shows every nucleotide (170 positions) in 
the MuLV dimerization domain RNA in an order determined by k-means clustering rather than linear 
sequence. Major kinetic clusters are labeled, and representative kinetic profiles and observed net rates are 
shown for each cluster. Rates are reported as the mean for all nucleotides in each cluster ± the standard 
deviation. Positions of nucleotides in each cluster are shown in structural cartoons below each kinetic 
profile, colored by rate: orange > green > red > black. For clarity, only one strand of the dimer is colored.  
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Figure 4.S2: Time-resolved SHAPE of the native sequence MuLV RNA dimerization at 600 nM and 
200 nM. Representative kinetic profiles and net rates are shown. Observed net rates were identical, within 
error, over a 3-fold RNA concentration range. Data shown in the 600 nM panel are the same as data 
shown in Fig. 4.2A. Nucleotides are shown in the order determined by k-means clustering rather than the 
5’ to 3’ nucleotide sequence order. 
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The preference of NC to interact at guanosine residues prompted us to consider whether NC 
exerts its RNA chaperone activity by destabilizing interactions between guanosine and other nucleotides. 
We explored the dimerization reaction using an RNA in which all guanosine residues were replaced by 
inosine, in essence removing a single amine group from each guanosine position. Inosine-cytosine pairs 
are iso-structural with guanosine-cytosine pairs, but are ~1 kcal/mol less stable (Fig. 4.4A); inosine also 
pairs more weakly with uridine than guanosine18. The guanosine-to-inosine substitution will thus reduce 
both the strength and the promiscuity of alternative base pairs during the RNA folding reaction. The 
inosine-substituted RNA formed essentially the same final dimer structure as the guanosine-containing 
MuLV domain as indicated by SHAPE-directed modeling19 (fig. S3A), and individual nucleotide SHAPE 
reactivities for the inosine and native MuLV domain dimers are strongly correlated (R2 = 0.88) (Fig. 
4.4B). Although the overall secondary structures for inosine and native RNAs in the monomer states are 
similar (fig. 4.S3, B and C), SHAPE reactivities correlate poorly (R2 = 0.26) (Fig. 4.4C). However, adding 
NC to the guanosine-containing monomer converts this RNA to a structure that has a SHAPE profile 
highly similar to that of the inosine RNA monomer (R2 = 0.87) (Fig. 4.4D). The inosine-substituted RNA 
is thus a good model both for the NC-destabilized native RNA in the monomer state and for the final 
dimer.  
 
Text 4.S2: In the dimerization domain, 50 of 170 nts (29%) of residues are guanosine, such that the 
observed preferential interactions with 66% and 52% of guanosine by NC and UP1 (Fig. 3), respectively, 
are greater than expected by chance; p-values (exact binomial test) are 0.00005 and 0.02, respectively. In 
addition, for both proteins, each of the seven most strongly protected nucleotides (positive amplitudes in 
Figs. 4.3A and 4.3D) are guanosine.  
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Fig. 4.3 Initial interactions between NC and UP1 with the MuLV monomer. (A and D) SHAPE 
difference plots illustrating the effect of (A) NC or (D) UP1 binding to the native dimerization domain 7 s 
after protein addition. Sites of strongest interaction, corresponding to SHAPE differences greater than 
20%, are highlighted in blue; those that occur at guanosine residues are labeled with a G. (B and E) 
Superposition of strongest initial interaction sites for (B) NC and (E) UP1 on a MuLV dimerization 
domain secondary structure model. Structures are colored by SHAPE reactivity before protein binding. (C 
and F) SHAPE difference plots illustrating the lack of an effect of (C) NC or (F) UP1 binding to the 
inosine-substituted RNA.  
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Fig. 4.4 Role of guanosine in RNA structure and mechanism of chaperone-mediated RNA folding. 
(A) Average stabilities (∆G°37) of nearest neighbor base pair combinations involving one G-C, I-C, or A-
U pair and one Watson-Crick pair in 1 M NaCl18,22, with representative structures. Standard deviations for 
the nearest-neighbors combinations are shown with lines. (B to D) Correlations between SHAPE 
reactivity profiles of (B) native and inosine-substituted dimers (obtained at 30 min dimerization time 
points), (C) native and inosine-substituted monomers (obtained just before addition of Mg2+), and (D) the 
native RNA after a 7-s interaction with NC versus the protein-free inosine-substituted monomer (both in 
the presence of Mg2+). The inosine dimer and native dimer in the presence of NC (not shown) also show a 
strong correlation (R2 = 0.89) reflecting that NC binds at relatively few sites in the native dimer (fig. 
4.S6). (E and F) Structures of (E) NC17 and (F) UP123 chaperones, emphasizing that both have a 
guanosine-binding pocket and that flanking nucleotides interact in an extended conformation. NC and 
UP1 bind guanosine in distinct ways involving anti and syn nucleotide conformations, respectively. (G) 
RNA-only (top) and chaperone-catalyzed (bottom) MuLV genome assembly mechanisms. Net rates are 
reported for each step. The overall reaction proceeds sequentially as indicated by (i) the change in 
reaction order (from second to first, yielding a large increase in effective RNA concentration) upon 
formation of the initial SL1-SL2 kissing interaction in the first step and (ii) the observation of biphasic 
profiles (Fig. 4.2) that include both the 1.6 and 0.1 min–1 processes. Evidence for a specific order of the 
0.3 min–1 process is less strong, and this step may occur in parallel with the 0.1 min–1 conformational 
change.   
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Figure 4.S3: Native and inosine-substituted RNA secondary structures. (A) SHAPE-directed 
secondary structure model19 for the inosine-substituted dimer. Nucleotides are colored by SHAPE 
reactivity; only one strand of the dimer is colored. Comparison of the SHAPE-directed secondary 
structures and free energies (ΔG°37) for the (B) native (guanosine-containing) and (C) inosine-substituted 
monomers. Free energies (ΔG°37) were calculated using either the standard parameters in RNAstructure27 
for the native RNA or a modified RNAstructure program incorporating inosine nearest-neighbor 
parameters. 
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Time-resolved SHAPE analysis of dimerization of the inosine-substituted RNA in the absence of 
NC revealed a single, fast kinetic step involving similar nucleotides as NC-mediated dimerization of the 
native sequence RNA (compare Fig. 4.2B and 2C). The dimerization rate of the inosine RNA was 
accelerated by a factor of 7 relative to that of the free native RNA. The NC protein does not affect the 
structure of the inosine-substituted RNA (Fig. 4.3C). A nondenaturing gel-based analysis confirmed that 
addition of NC protein had no effect on the rate of formation of the final dimer state for the inosine-
substituted RNA (fig. S4). Replacement of guanosine with inosine thus both abrogates most of the need 
for the RNA chaperone activity of the NC protein and converts the RNA into a form that folds via a 
simple and direct pathway (compare Fig. 4.2A and 2C).  
The unwinding domain of the heterogeneous nuclear ribonucleoprotein (hnRNP) A1 protein 
(UP1) contains an arginine-rich RNA recognition motif and has potent RNA chaperone activity1,20. UP1 
has no structural similarity with NC except that both proteins contain clefts that bind guanosine (Fig. 4.4, 
E and F). As in the presence of NC, UP1-mediated dimerization of the MuLV domain proceeded in a 
single, fast kinetic step (fig. 4.S5) accelerated by a factor of ~20 (kobs > 2 min–1) relative to the RNA 
alone. Of the initial interaction sites (at ~7 s) for UP1 on the native monomer RNA, 52% were guanosine 
residues (Fig. 4.3D and text 4.S2). The set of guanosines contacted most strongly by UP1 included some 
but not all of the guanosines contacted by NC (compare Fig. 4.3B and 3E). UP1 had no effect on the 
dimerization rate of the inosine-substituted RNA (Fig. 4.3F and fig. 4.S4). UP1 is not known to play a 
role in structure rearrangements for the MuLV RNA genome, yet is a potent facilitator of RNA 
dimerization of the MuLV domain and does so by a mechanism similar to the cognate NC chaperone.  
Our data support a model of MuLV genomic dimerization in which two MuLV monomers initially 
associate rapidly via loop-loop interactions; subsequent steps for RNA-only folding are complex, involve 
multiple intermediates, and proceed slowly (Fig. 4.4G). In the presence of the chaperone, RNA 
dimerization was accelerated by a factor of more than 10 and appeared to occur in a single kinetic step, 
indicating that the chaperone function accelerated multiple classes of slow RNA conformational changes 
(Fig. 4.4G). Our data indicate that RNA chaperones NC and UP1 both act by binding to exposed 
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guanosine residues in RNA, thereby destabilizing stronger base pairings and creating a simplified folding 
pathway (text 4.S3). The two proteins contact distinct, partially overlapping sets of guanosine residues in 
their initial interactions with RNA; thus, many possible guanosine-binding activities may support RNA 
chaperone function. The NC and UP1 chaperones also bind to the final native sequence dimer in patterns 
that are distinct from their initial interactions with the monomer state (fig. 4.S6). These data suggest that 
chaperone binding does not discriminate between folded and misfolded RNA states per se but that 
guanosine nucleotides are ultimately arranged in the final structure in such a way that chaperone binding 
(or inosine substitution) does not overly destabilize the final RNA structure. In this way, a guanosine-
centric mechanism for RNA chaperone function is analogous to the mechanism of some chaperones that 
facilitate protein folding that destabilizes interactions involving hydrophobic amino acid residues21. In 
these cases, both RNA and protein chaperones simply interact with residues especially prone to forming 
stable intermediate and non-native states. 
 
Text 4.S3: The NC and UP1 chaperone exhibited all of the activities attributed to non-specificRNA-
binding chaperone proteins – including RNA annealing, strand exchange, destabilization ofintermediates, 
facilitating complex structural rearrangements, and the ability to act on large RNAregions 
simultaneously1,3,4 (and see Figs. 4.2 and 4.S6), and were largely mediated byinteractions between NC or 
UP1 and guanosine nucleotides. The guanosine-centric mechanismoutlined here imposes very few 
requirements on a potential RNA chaperone, primarily that itcontains a binding pocket for guanosine (see 
Figs. 4.4E and 4.4F), and therefore is likely to apply to a wide variety of chaperone proteins. There are 
other mechanisms by which RNA chaperones can function, however. These include via ATP-dependent 
mechanisms31, as macromolecular complexes32, and as non-specific RNA binding proteins that interact 
locally with RNA via mechanisms that are independent of guanosine nucleotides.  
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Figure 4.S4: Visualization of MuLV genomic RNA dimerization by non-denaturing electrophoresis. 
Dimerization time courses are shown for 600 nM (A) native and (B) inosinesubstituted RNAs with and 
without 8 μM NC or UP1. (C) Fraction of RNA dimer as a function of time. Points are fit assuming a first 
order process. Observed net rates for the native, native + NC, and native + UP1 experiments were 0.12 ± 
0.05, 1.4 ± 0.3, and >2 min–1 respectively; and for the inosine RNA, inosine RNA + NC, and inosine 
RNA + UP1 were 0.8 ± 0.1, 0.7 ± 0.1, and 0.8 ± 0.2 min–1 respectively. These rates correspond well to a 
subset of the rate process detected by nucleotide-resolution time-resolved SHAPE (Figs. 4.2, 4.S2, and 
4.S5). 
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Figure 4.S5: Time-resolved SHAPE of UP1-mediated RNA dimerization of the native MuLV RNA. 
Each data point is shown on a scale (black to red) corresponding to its SHAPE reactivity. Major kinetic 
clusters are labeled and representative kinetic profiles and observed net rates are shown for each cluster. 
The effect of UP1-facilitation is readily seen by comparing this figure to Fig. 4.2A. Nucleotides are 
shown in the order determined by k-means clustering.  
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Figure 4.S6: Interactions between NC and UP1 with the MuLV monomer and dimer states. 
SHAPE difference plots illustrating the effect of (A, B) NC or (D, E) UP1 binding to the initial monomer 
and final dimer states. Site of strongest interaction, corresponding to SHAPE differences greater than 
20%, are highlighted blue; those that occur at guanosine residues are labeled with a G. Black bars in panel 
B denote specific NC binding sites that mediate RNA genome packaging10. Superposition of strongest 
interaction sites for (C) NC and (F) UP1 on a model for the MuLV domain secondary structure in the 
final dimer state. Data shown in panels A and D are also shown in Fig. 4.3.  
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Chapter 5: An Investigation of Heterogenous Ribonuceloprotein A1 and Unwinding Protein 1 DNA 
Binding Characteristics 
 
INTRODUCTION: 
 Heterogenous ribobucleoprotein complex (hnRNP) A1 is one member of a family of hnRNPs that 
associates with heterogenous nuclear RNA (hnRNA), also known as precursor RNA (pre-RNA). hnRNPs 
facilitate the excision of introns from hnRNA and the assembly of mature messengers RNAs (mRNAs) 
via process known as splicing1. However, hnRNP A1 has also been found to mediate a wide variety of 
other cellular and viral processes. Significantly, hnRNP A1 has been found to bind specifically to 
telomeric DNA2 and to facilitate telomere maintenance3, possibly by promoting telomerase activity4. A 
proteolytic fragment of hnRNP A1 called Unwinding Protein 1 (UP1), shares some of these properties. At 
the time our investigation of hnRNP A1 was begun (Early 2010), the role of hnRNP A1 in telomere 
biology remained only poorly understood. We hoped to characterize the binding properties of hnRNP A1 
on telomeric DNAs. This initial characterization would have provided a foundation for later work, 
including determining relative binding affinity of POT1 and hnRNP A1 to telomeric ssDNA overhangs. 
However, the binding of hnRNP A1 to a variety of both telomeric and non-telomeric ssDNAs was not 
amenable to examination via electron microscopy. Moreover, several groups published papers regarding 
the role on hnRNP A1 in telomere biology after this project was begun5, 6, or reported that they were 
aggressively investigating this topic at the 2011 Cold Spring Harbor meeting on Telomeres and 
Telomerase. For these and other reasons we abandoned our investigation of hnRNPA1 in July of 2011. 
Future studies with G-rich telomere-derived RNA (TERRA), however, remain of potential interest. The 
cloning and generation of a simple hexahistidine tagged hnRNP A1 expression vector, done in this work, 
has provided a useful tool for future work at UNC and elsewhere. 
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MATERIALS AND METHODS: 
DNAs and Templates 
pRST5, pRST5Nick and pGLGAP were prepared as previously described8, 9. To generate the 
strand-displaced templates pGL GAP and pRST5Nick was nicked using Nb.BbvCI (New England 
Biolabs) and pRST5 was nicked with Nb.BsmBI (New England Biolabs), and the resulting 3’ hydroxyl 
was used to prime an elongnation reaction using DNA Polymerase I Exo(-) (New England Biolabs) 
containing dATP, dTTP and dGTP. to generate a model telomere, pRST5 was cut with BsmBI (New 
England Biolabs) and exonucleolytically digested with T7 Exonuclease (New England Biolabs) to 
generate a G-rich telomeric and a quasi-random 3’ tail on either end of the linear dsDNA.  
 
Proteins: 
A quantity of purified hnRNP A1 was received as a generous gift from Dr. Adrian Krainer, which 
was used in some of our initial experiments. Most data is derived from hnRNP A1 expressed in and 
purified from E. coli. Previous work had employed calf tissue and a more-complicated purification 
procedure. A plasmid containing the hnRNP A1 cDNA (NM_002136) was purchased from a commercial 
vendor (Open Biosystems: Cat#IHS1380-97433308). This cDNA or a fragment of this cDNA coding for 
UP1 were ligated into a HIS-Tagging protein expression vector, pET28a (Invitrogen), via conventional 
cloning. Proper assembly of the final vectors was confirmed via bidirectional sequencing (MWG 
Operon). The assembled vectors were individually transformed into chemically competent 
BL21(DE3)PlysS cells via heat shock and grown on LB-Agar plates supplemented with 10 μg/ml 
kanamycin sulfate (Kan). Individual colonies were used to serially inoculate LB+Kan cultures until  
2x500 ml cultures reached an optical density  (OD) at 595 nm of 0.6. Protein expression was then induced 
in these cultures via addition of Isopropyl β-D-1-thiogalactopyranoside (IPTG) at a final concentration of 
1 mM. Cultures were induced at 37 °C for 2 h in a shaking incubator. Cells were then recovered by 
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centrifugation and resuspended in lysis buffer (50mM Tris-HCl at pH 7.4, 8mM β-MeOH, 300mM NaCl) 
supplemented with  1x protease inhibitors ( EDTA Free Complete ® Tablets) and stored at -80 °C. Cells 
were thawed and lysed via addition of 1 mg/ml egg-white lysozyme and sonication and the crude lysate 
separated via ultracentrifugation in an SW-27 rotor at  27,000 RPM for 2 h. The supernatant was collected 
and passed through a 20 ml Fast Flow DEAE-Sepharose (Amersham Pharmacia) equilibrated in lysis 
buffer and was collected in the flowthrough fraction. This flow through was then applied to 2 ml of 
NiNTA agarose (Qiagen) equilibrated in lysis buffer supplemented with 50 mM imidazole. The protein 
was then eluted following thorough washing of the beads with 50mM Imidazole and a stepwise gradient 
to 500mM imidazole. The obtained protein was then dialyzed overnight against storage buffer (20% 
glycerol, 300mM NaCl, 5mM βME, 20mM Tris-HCl pH 7.4), aliquoted, flash frozen over liquid nitrogen, 
and stored at -80 °C. Proteins were quantified via Bradford (Biorad) calibrated against a bovine serum 
albumin control. 
 
Electron Microscopy:  
Carbon was evaporated onto freshly cleaved mica under vacuum in a modified DV-502A 
(Denton), and this carbon foil was then floated onto a surface of double-distilled water. 400 mesh EM 
grids (Ted Pella Inc.), were then briefly dipped in 5% polyurethane diluted in toluene and then partially 
dried via blotting on filter paper. These grids were then placed face down atop the floating carbon film 
and allowed to adhere overnight at room temperature. The grids were then recovered using a tensioned 
film of plastic wrap, transferred to filter paper and allowed to dry at room temperature. Hand-made size 
exclusion columns for use in cleaning samples prior to examination by electron microscopy were  
manufactured via addition of  approximately 2 ml of A5M Agarose Beads (Agarose Beads Technology) 
to a disposable 2.4 ml transfer pipette (Fisher 13-711-5AM) stoppered with glass wool. These columns 
were then equilibrated with 10x column volumes of EM-grade TE (EMTE; 10 mM Tris-HCL at pH 7.5, 
0.1 mM EDTA) and clamped at the tip until use. As necessary samples were fixed prior to cleaning via 
addition of 0.3 % to 0.6 % (v/v) glutaraldehyde and incubation at either room temperature or 0 °C for 5 
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min. Samples were passed over A5M columns via addition of a 50 μl sample to the center of the top of 
the bead bed of an equilibrated and flowing A5M column, followed by dropwise addition of EMTE to the 
column. Purified samples were recovered in fractions obtained immediately after an approximately 650 μl 
void volume. In preparation for examination of samples by electron microscopy, carbon foil coated 
copper grids were subjected to glow discharge in a modified DV-502A (Denton) to render the carbon 
hydrophilic. Purified samples and samples not requiring purification were then countercharged via 
addition of 1x spermidine buffer (2.5 mM spermidine, 75 mM NaCl, 50 mM KCl, 10 mM Tris-HCl at pH 
7.5, 1 mM MgCl2, 0.25 mM CaCl2). Countercharged samples were then immediately applied to charged 
carbon grids and incubated at RT for 3 min, then briefly washed in distilled water, then incubated in a 
separate distilled water bath for 3 min. The samples were then dehydrated in successive 25%, 50%, 75%, 
and 95% (v/v) ethanol baths for 5 min per bath. Samples were then air dried and tungsten shadow cast in 
a modified DV-502a (Denton) equipped with a rotating stage. Shadowed grids were then stored under 
vacuum at room temperature until examination using either a Tecnai-12 (FEI) or a CM-12 (Phillips) 
transmission electron microscope.  
 
Dynamic Light Scattering 
The samples were injected into a Superdex 75 column followed by two 5 ml Sephadex G50 
columns (GE Healthcare). The column outlet was connected to a Dawn EOS multiangle, static, light 
scattering detector (Wyatt Technology Corporation, Santa Barbara, CA). Average molar mass 
measurements were determined from aligned elution profiles within ASTRA for Windows software 
(version 5.3.4.16; Wyatt), using the Debye plot. Detectors 3 to 8 were used. 
 
RESULTS: 
hnRNP A1 & UP1 bind to ssDNA 
 We sought to validate the DNA binding activities of our purified hnRNP A1 via a combination of 
electrophoretic mobility shift assays (EMSAs) and electron microscopy (EM). hnRNP A1 binding to M13 
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ssDNA was observed to be non-cooperative. As successively higher concentrations of hnRNP  A1 were 
incubated with M13 ssDNA the ssDNA was shifted into complexes of progressively lower electrophotetic 
mobility, consistent with stable hnRNP A1 binding (Figure 5.1). The detected bands were not derived 
from contaminating nucleic acids, as a reaction containing high concentrations of hnRNP A1 but no M13 
yielded no detectable band (Figure 5.1, lane 2). The observed shifts in electrophoretic mobility were 
protein mediated, as subsequent incubation of a reaction containing 300 μg/ml hnRNP A1 with SDS and 
proteinase K increased abolished the observed mobility shift (Figure 5.1, lane 9). UP1 exhibited broadly 
comparable binding activities (data not shown). 
 
  
Figure 5.1 Electrophoretic mobility shift assay demonstrating hnRNP A1 ssDNA binding. hnRNP 
A1 induces progressively severe retardation of M13 electophoretic mobility with increasing protein 
concentration (lanes 2-8). The observed bands consist of M13 ssDNA, as the band is not observed when 
M13 is omitted even in the presence of high concentrations of hnRNP A1 (lane 2). The observed shift in 
mobility is protein-mediated, as the shift can be abolished upon incubation with SDS and proteinase K 
(lane 9).  
 
 
EM examination revealed that hnRNP A1 bound to M13 as large, heterogenous, and occasionally 
oligomeric complexes (Figure 5.2). While hnRNP A1 binding to M13 did occasionally generate an open 
structure reminiscent of that formed when E.coli single-stranded DNA binding proteins binds to M13 
(e.g. Figure 5.2C), most particles were condensed and not amenable to examination by electron 
microscopy. In solution, hnRNP A1 appeared as a large quasi-spherical particle, with an apparent volume 
greater than anticipated for its hypothetical molecular weight of 38 kDa (Figure 5.2,B). 
It has previously been reported the hnRNP A1 exhibits binding cooperatively10, but that this 
binding cooperativity is lost upon freezing or prolonged storage11. The reason for this change in binding 
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properties has not been described in available literature, but may involve protein aggregation or 
denaturation. To investigate possible aggregation or oligomerization of hnRNP A1, we submitted a 
quantity of hnRNP A1 to Dr. Mehmet Kesimer for analysis via dynamic light scattering (DLS). The 
obtained DLS data was of low quality, possibly stemming from low protein concentration and inefficient 
chromatographic separation of the protein species (Figure 5.3) However, the data was still interpretable 
and suggested that in solution our hnRNP A1 existed predominately as monomeric protein with an 
estimated mass of 46 ± 3 kDa (Peak 1). While this is greater than the expected mass of 38 kDa, this 
number is affected by the low quality of the data. hnRNP A1 was also found to exist as an approximately 
640 kDa complex (Peak 2), possibly due to the presence of some residual contaminating nucleic acids in 
the purified proteins or DNA independent hnRNP A1 oligomerization. The presence of contaminating 
nucleic acids would be expected to nucleate binding of hnRNP A1 and permit the formation of larger 
complexes. This second peak was calculated to constitute approximately 21% of the total protein in 
solution, but as this peak overlaps the shoulder of Peak 1, such quantification is likely overestimated. 
Finally, DLS also reported the existence of a peak of very high mass, in excess of several megadaltons 
(Peak 3). As with peak 3, this may be due to the presence of contaminating nucleic acids or it may 
represent a very high mass contaminant not removed by the hnRNP A1 purification procedure. The 
calculated masses and abundances of these proteins must be taken with caution, as they are substantially 
affected by analysis. Subsequent re-analysis suggested Peak 1 had a mass of 37 kDa, much closer to the 
expected 38 kDa mass (Dr. Kesimer, personal communications). Re-analysis also reduced the expected 
abundance of Peak 3 protein to approximately 20 nanograms. Regardless, these data suggest that the 
purified hnRNP A1 did not suffer from high amounts of aggregation during purification or storage.  
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Figure 5.2: hnRNP A1 binds to M13 ssDNA. (A) M13ssDNA. (B) hnRNP A1 not bound to M13. (C) 
hnRNP A1 bound to M13 ssDNA.  
 
 
 
Figure 5.3 Dynamic light scattering reveals mostly homogenous hnRNP A1. hnRNP A1 was observed 
to exist as three popultions of particles. Peak 1 possessed an apparent molecular weight of in excess of 2 
megadaltons, but accounted for less than 10% of the total protein in solution. Peak 2 possessed an 
apparent mass of 640 kilodaltons and accounted for 22% of the total protein. Peak 3 possessed an 
apparent mass of 46 kilodaltons and accounted for about 71% of total protein.  
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hnRNP A1 binds preferentially to telomeric ssDNA 
We next sought to investigate the binding characteristics of hnRNP A1 and UP1 on templates 
containing telomeric and non-telomeric ssDNA and dsDNAs. hnRNP A1 binding was observed to bind to 
strand-displaced telomeric DNA (Figure 5.4B) as a zone of higher electron density not observed in the 
absence of hnRNP A1 (Figure 5.4D). In contrast, hnRNP A1 was not observed to bind significantly to 
strand-displaced non-telomeric ssDNA (Figure 5.4A). However, a small zone of high electron density was 
observed on strand-displaced non-telomeric ssDNA in the absence of hnRNP A1 (Figure 5.4C), that was 
comparable to that observed in the presence of hnRNP A1. 
 
Figure 5.4 hnRNP A1 binds to strand displaced telomeric but not non-telomeric DNA. (A) hnRNP 
A1 does not bind to strand displaced non-telomeric ssDNA. (B) hnRNP A1 does not bind to strand 
displaced non-telomeric ssDNA. (C) hnRNP A1 does not bind to strand displaced non-telomeric ssDNA. 
(D) hnRNP A1 does not bind to strand displaced non-telomeric ssDNA.  (E) Diagram of strand displaced 
templates; templates are nicked with Nb. BbvcI then strand displaced with Klenow Exo(-) with dATP, 
dTTP and dGTP. Strand displacement stops at a defined nucleotide leaving ssDNA tails of defined length.  
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To investigate hnRNP A1’s apparent binding preference for telomeric ssDNA, we tested it’s 
binding to a linear dsDNA possessing telomeric 3’ ssDNA tails of telomeric or non-telomeric sequence 
on either end (Figure 5.5C).  At a fixed concentration, hnRNP A1 was observed to bind to one end of the 
template more frequently than would be expected if hnRNP A1 binding to the two ssDNA tails was non-
specific (Figure 5.5A). Likewise, hnRNP A1 bound two both ends less frequently than would be expected 
if hnRNP A1 binding was non-specific. These data suggest that hnRNP A1 binds preferentially to one end 
of the template, through this experiment did not explicitly identify which.  
 
Figure 5.5 hnRNP A1 binds preferentially to one end of a template with telomeric and non-
telomeric ssDNA on opposite sides of a linear template. (A) Abundance of particles with hnRNP A1 
bound to one, both or neither compared with those expected if binding was random. (B) particle with an 
example of hnRNP A1 binding on one end (bottom) and not on the other end (top). (C) Diagram of 
template; plasmid it cut with BsmBI then exonucleolytically digested with Exonuclease 3 to expose 
ssdNA.  
 
 
In a subsequent experiment we characterized the binding of hnRNP A1 and SSB to similar 
templates possessing only a 3’ telomeric ssDNA tail (Figure 5.6). On these templates, the tails could be 
readily detected by the binding of E. coli single-stranded DNA binding protein (SSB) (Figure 5.6A), 
101 
 
which stretched the ssDNA to form a filamentous structure. In contrast, hnRNP A1 binding resulted in the 
formation of the ball-like complexes previously observed (Figure 5.6B). These structures were distinctly 
different from those observed on the template in the absence of any added protein (Figure 5.6C).  
 
Figure 5.6 Comparative binding of E. coli and hnRNP A1 to exposed telomeric ssDNA. (A) E. coli 
SSB bound to exposed telomeric ssDNA. (B) hnRNP A1 bound to exposed telomeric ssDNA. (C) 
Templates with exposed telomeric ssDNA.  
 
 
 
We attempted to optimize buffer conditions to generate more specific hnRNP A1 binding by 
varying salt, glycerol and dithiothreitol (DTT) concentration (Figure 5.7). Increasing the sodium chloride 
concentration in a reaction buffer containing 25 mM HEPES and 0 mM DTT (Figure 5.7A) to 0.5 mM 
(Figure 5.7B), 2.5 mM (Figure 5.7C) or 5 mM (Figure 5.7D) seemed to result in greater hnRNP A1 
binding but not the formation of any interesting binding structures. Likewise increasing the glycerol 
concentration to 1% (Figure 5.7E), 5% (Figrue 5.7F) or 10% (figure 5.7G) did not appear to significantly 
affect hnRNP A1 binding. Finally, similarly increasing the sodium chloride concentration to 100 mM  
(Figure 5.7H), 200 mM  (Figure 5.7I) or 300mM (figure 5.7E) suggested that inclusion of 200mM NaCl 
may improve hnRNP A1 binding, though this trend was not clear.  
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Figure 5.7: Optimization of hnRNP A1 binding conditions. (A) binding in 25 mM HEPES. (B) +0.5 
mM DTT (C) +2.5 mM DTT. (D) +5 mM DTT. (E) +1% Glycerol. (F) +5% Glycerol. (G) +10% 
Glycerol. (H) +100 mM NaCl. (I) +200 mM NaCl. (J) +300 mM NaCl.   
 
 
We likewise attempted to optimize buffer conditions to generate specific UP1 binding by varying 
salt, glycerol and dithiothreitol (DTT) concentration (Figure 5.7). Increasing the sodium chloride 
concentration in a reaction buffer containing 25 mM HEPES and 0 mM DTT (Figure 5.8A) to 2.5 mM 
(Figure 5.8B) or 5 mM (Figure 5.8C) did not appear to affect UP1 binding. Likewise increasing the 
glycerol concentration to 1% (Figure 5.8D), 5% (Figure 5.8E) or 10% (figure 5.8F) did not appear to 
significantly affect UP1 binding. Finally, as with hnRNP A1 increasing the sodium chloride concentration 
to 100 mM  (Figure 5.8G), 200 mM  (Figure 5.8H) or 300mM (figure 5.8I) suggested that inclusion of 
200 mM NaCl may improve UP1 binding, though this trend was not clear.  
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 Figure 5.8: Optimization of UP1 binding conditions. (A) binding in 25 mM HEPES. (B) +2.5 mM 
DTT (C) +5 mM DTT. (D) +1% Glycerol. (E) +5% Glycerol. (F) +10% Glycerol. (G) +100 mM NaCl. 
(H) +200 mM NaCl. (I) +300 mM NaCl.   
 
 
Possible deleterious effects of N-terminal tagging 
Dr. Adrian Krainer reported that the binding and catalytic activities of hnRNP A1 may be 
disrupted by N-terminal tagging (personal communication). hnRNP A1 and UP1 binding are mediated 
primarily by two RNA recognition motifs (RRMs) in the N-terminal region of the protein12, 13. While the 
amino terminus of hnRNP A1 and UP1 are solvent exposed and separated from the RRM domains 
spatially, the addition of a 3.5 kDa hexahistidine tagged linker may disrupt either the binding of these 
domains or affect the oligomerization of these proteins.  Additionally, hnRNP A1 is post-translationally 
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modified in vivo, via processes that are not present in E. coli, but which are active in eukaryotic 
expression systems such as insect cells (reviewed in1). We did not observe qualitative differences in 
binding of n-terminally hexahistidine tagged E. coli purified hnRNP A1 or untagged baculovirus purified 
hnRNP A1 obtained from Dr. Krainer, though our data was not of sufficient quality to discount such a 
possibility (data not shown).  
 
DISCUSSION 
Our attempt at characterizing the DNA binding characteristics of hnRNP A1 and UP1 in vitro 
using electron microscopy did not yield data of sufficient quality for publication. Despite numerous 
attempts at optimizing buffer and reaction conditions, to promote specific binding of these proteins into 
discernable structures, the proteins always bound as large complexes. These complexes may represent 
physiologically relevant oligomerization, but they are also consistent with undesirable aggregation.  
hnRNP A1 has been reported to bind cooperatively on both RNA10 and DNA11, but the solution structure 
of full-length hnRNP A21 has not been solved and oligomerization domains for hnRNP A1 have not been 
identified or characterized14. As such, it remains unclear whether hnRNP A1 does indeed multimerize in 
solution, or upon binding and likewise whether this multimerization is required for hnRNP A1’s binding 
activities.  
While it is possible that further optimization may have permitted us to generate higher quality 
data, this project was terminated in large part due to competition from other laboratories. In March 2011 a 
collaborative effort involving the laboratories of Dr. Sandy Change, Dr. Jan Karlseder, Dr. Zhou 
Songyang reported that hnRNP A1 and telomere derived RNA (TERRA) may facilitate removal of RPA 
from telomeric DNA to permit POT1 binding6. As our preliminary results did not generate any data that 
was compelling we chose to put the project on hold.  
Sometime later, we received word from our collaborator, Dr. Adrian Krainer, that our N-terminal 
tagging of hnRNP A1 and UP1 may have adversely affected their activities. Dr. Krainer’s research has 
long focused on E. coli purified but untagged hnRNP A116. While it is plausible that our N-terminal 
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tagging strategy did in fact adversely affect hnRNP A1’s binding activities, our purified UP1 proved to be 
active as an RNA chaperone in a separate project7. Whether this is because the binding activities of 
hnRNP A1 and its proteolytic fragment, UP1, are different or whether the chaperone activities and 
binding activities are independent of each other is unclear. While we could have re-purified hnRNP A1 
and UP1 using techniques similar to Dr. Krainer’s, it remained unclear whether we could actually use EM 
to answer any scientifically interesting questions.  
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Chapter 6: Conclusions and Final Thoughts 
 
 Presented in this thesis are data from selected work from my tenure as a graduate student in the 
laboratory of Dr. Jack Griffith, at the University of North Carolina at Chapel Hill. The overriding goal of 
my dissertation was to gain an understanding of functional interactions between TRF2 and Rad51 
recombinase. I chose to focus on the in vitro interaction of these proteins in a displacement loop (D-loop) 
assay. The activity of Rad51 has been characterized using in vitro D-loop and strand displacement assays, 
and the activities of TRF2 had previously been characterized using a similar D-loop assay by the 
laboratory of Dr. Eric Gilson and in cell extracts by Dr. Jan Karlseder. Prior to undertaking this 
characterization a student, Ravindra Amunugama, of our collaborator, Dr. Rick Fishel, reported 
modifications to established D-loop protocols that increased the efficiency of those reactions. This made 
it plausible to examine the functional interaction of TRF2 and Rad51 in a D-loop assay modified from 
previous TRF2 and Rad51 characterizations. Using this assay we sought to determine in vitro whether 
TRF2 and Rad51 exhibit functional cooperation, as suggested by earlier work from the laboratory of Dr. 
Karlseder, or whether TRF2 and Rad51 may exhibit functional antagonism, which might be expected 
given their previously characterized in vitro activities. Dr. Gilson had reported that TRF2 promotes 
telomeric D-loop formation by promoting positive supercoiling within telomeric dsDNA, while Rad51 
has previously been reported to promote D-loop formation optimally on negatively supercoiled DNA.  
 
Homologous recombination/repair in telomere maintenance & protection  
The results of our characterization of the functional interaction of TRF1, TRF2 and Rad51 
include several novel findings that offer insight into how HR may promote telomere maintenance and 
protection, and how TRF2 may promote non-telomeric DSB repair. These results agree with some 
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previous findings and contradict others, and suggest that the activities of these proteins in vivo must be 
modulated by factors absent from our and other in vitro characterizations.  
Reviewers of our paper raised the criticism that our results appeared to contradict a report from 
Dr. Karlseder’s lab that Rad51 and TRF2 functionally cooperate to promote telomeric D-loop formation 
in nuclear extracts1. However, it is difficult to compare the results of these assays for methodological 
reasons. Most importantly, nuclear extracts contain a host of proteins that may influence the activities of 
TRF2 and Rad51 that were absent from our characterization. This notion is supported by a recent report 
that TRF2 inhibits HR mediated processes at humanized yeast telomeres2. Determining the reason or 
reasons for these discrepancies will require a more-detailed understanding of the mechanisms of the 
functional interactions between TRF2 and proteins in the HR pathway.  
Our results revealed that TRF1, TRF2 and Rad51 exhibit functional interactions. However, we 
were unable to identify specific domains that mediate these interactions. We showed that TRF2 inhibited 
Rad51 mediated telomeric D-loop formation in a Myb domain dependent manner. However, we also 
observed that TRF1, which possesses a homologous Myb domain to TRF2, actually promoted Rad51-
mediated telomeric D-loop formation. In contrast, we observed that the basic domain was dispensable for 
TRF2’s inhibition of Rad51 mediated telomeric D-loop formation. Taken together these data suggest that 
TRF2’s Myb domain is necessary but not sufficient for inhibiting Rad51-mediated telomeric D-loop 
formation. It appears likely that the Myb domain is instead required for the recruitment of some portion of 
the linked or dimerization domain that itself inhibits Rad51-mediated telomeric D-loop formation. Work 
from Dr. Eric Gilson’s lab suggests that TRF2’s dimerization domain mediates TRF2’s ability to promote 
positive supercoiling within telomeric dsDNA3. As Rad51 promotes D-loop formation most efficiently 
when acting on negatively supercoiled templates, we speculate that TRF2’s ability to promote positive 
supercoiling may also be required for its inhibition of Rad51-mediated telomeric D-loop formation. 
However, the dimerization domain in unamenable to mutation and loss of dimerization also disrupts Myb 
domain binding. We tested the ability of a TRF2 mutant allegedly hypomorphic for supercoiling 
induction but competent for dimerization, which was described by Dr. Gilson at the 2013 CSH meeting 
110 
 
on Telomeres and Telomerase, to inhibit Rad51-mediated telomeric D-loop formation. However, this 
mutant inhibited Rad51-mediated telomeric D-loop formation in a manner comparable to TRF2. 
Ultimately, in the future identification of the domain that mediates TRF2’s inhibition of Rad51-mediated 
telomeric D-loop formation may require cloning and expressing additional TRF1 and TRF2 dimerization 
and linker domain mutant proteins, possible including domain swap proteins.  
The fluorescent D-loop assay we have used in this assay was adapted from previous 
characterization of both Rad514 and TRF23, with advice from Dr. Amunugama. We chose to modify the 
previously described techniques mostly due to the tedious nature of using conventional radiolabeled D-
loop assays. Such assays use 32P labeled oligonucleotides, which must be of very high specific activity to 
generate satisfactory results. As such the labeled oligonucleotides must be used almost immediately after 
labeling and must be frequently re-made. Additionally, the agarose gels used for such assays must be 
dried prior to imaging, and we found that the drying process tended to promote diffusion of the oligo 
throughout the gel and that the oligo was poorly retained within the gel throughout the drying process. 
Additionally, imaging the gels required a several hour or overnight exposure. We circumvented all of 
these technical issues by using commercially purified Cy3 labeled oligo, which did not decay and which 
could be rapidly imaged in an undried gel. This innovation allowed us to greatly increase the throughput 
of our experiments. This assay could be modified to conduct characterizations of functional interactions 
between Rad51 and BRCA2 or the Rad51 paralogs, topics which are of considerable interest.  
 
Intra-capsid AAV genome organization is unamenable to EM characterization 
During my collaboration with Dr. Horowitz I attempted to characterize the intra-capsid 
organization of self-complimentary AAV genomes using electron microscopy using several techniques. 
These characterizations did not yield usable results, but were complicated by lack of a good positive 
control. The most promising of our protocols involved using psoralen and ultraviolet A light (PUVA) in 
an attempt to crosslink portions the self-complimentary AAV genome in an intact viral capsid. After 
PUVA treatment we then thermally denatured the virions at high temperatures in the presence of an 
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extremely thermostable single-stranded DNA binding protein (ETSSB), which would immediately bind to 
any available ssDNA in the scAAV genomes. In a negative control which was not UV irradiated and 
where we used no SSB we slowly cooled the DNA to permit proper base pairing after denaturation. The 
negative control was observed to consist of fully double-stranded DNA, as expected. A positive control 
that was not UV irradiated but was exposed to ETSSB was observed to consist of fully ET SSB coated 
DNA, as expected. Experimental samples that were UV irradiated following treatment with varying 
concentrations of psoralen and exposed to ETSSB were indistinguishable from the positive control. These 
data suggested that the PUVA treatment failed to crosslink the scAAV genomes inside the capsid 
proteins. However, we failed to run a control to demonstrate the PUVA treatment could crosslink a non-
encapsidated scAAV genome. To do this we should have thermally denatured and renatured scAAV 
genomes, as in our negative control, then subsequently subjected them to PUVA treatment, denaturation 
and SSB. This control would be expected to show evidence of PUVA crosslinking, which would manifest 
as incomplete ETSSB binging along the scAAV genome.  
Ultimately, our collaborators decided not to repeat this experiment with our recommended 
controls, likely because data from a discreet molecular dynamics (DMD) model suggested that the 
scAAV genomes were partially double stranded when packaged in the viral capsid. However, there was 
evidence in the literature suggesting the PUVA approach had merit12. Psoralen has been reported to 
potentiate UV inactivation of AAV, suggesting that the AAV genome is capable of at-least limited base 
pairing inside the capsid and that the capsid is indeed psoralen permeable12. As the DMD model used in 
the publication possessed numerous simplifications13, it may prove worthwhile to validate the finding 
using the PUVA technique. This experiment would require collaboration with the Laboratories of Dr. 
Aravind Asokan or another AAV researcher as the quantity of AAV required for the PUVA procedure is 
non-trivial. However, such an undertaking is of defined and limited scope and short duration. It would 
require little if anything in the way of new reagents and would only require optimization of the PUVA 
procedure and validation of the appropriate positive and negative controls.  
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